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Abstract 
 
Objectives: This research aimed to study the antidiabetic effect of the 
aqueous and methanolic extracts of the seeds of Cicer arientinum, the bark 
of Cinnanomum verum and the leaves of Citrus aurantifolin in adult Wistar 
Albino rats.  
Methodology: Type II diabetes mellitus was induced using 
intraperitoneal loading dose of glucose while type I was induced using 
intraperitneal dose of Streptozotocin. Glucose tolerance test was adopted to 
follow the glucose level after administration of plant extracts. Blood samples 
for measurement of glucose, cholesterol and triglycerides were collected 
from the Retro-orbital plexus of the eye using heparinized capillary tubes. 
For type II diabetes blood samples were collected every one hour for four 
hours while for type I they were collected every four hours for twelve hours. 
Glibenclamide was chosen as a reference drug for type II and Insulin was 
chosen for type I. Furthermore these plants were investigated for their 
toxicological effects in terms of their actions on liver functions, kidney 
functions, blood haemoglobin, total white and red blood cells count. Even 
further, these plants were phytochemically screened for investigation of their 
chemical constituents 
Results: The findings of this research showed that all plants revealed 
a pronounced hypoglycaemic effect. Concerning type II, the most significant 
effect (P≤0.001) was exerted by the extracts of Cinnanomum verum, 
throughout the experiment as compared to the control and to the reference 
drug Glibenclamide. Concerning type I, the aqueous extract of Cicer 
arientinum, showed an early onset of hypoglycaemic effect which started 
since the first hour, while Cinnanomum verum and Citrus aurantifolin 
 XIII
showed a significant glucose reduction (P≤0.001) two and four hours post 
dosing, as compared to the control and the reference drug Insulin. 
Concerning the hypolipidaemic effect in type II, the methanolic extract of 
Cicer arientinum, showed a significant reduction (P≤0.001) in the levels of 
blood cholesterol and triglycerides, throughout the experiment. In type I, 
Citrus aurantifolin reduced blood triglycerides significantly (P≤0.001) since 
the first hour. The findings of the toxicological study revealed no alteration 
in the normal liver and kidney functions as well as haemoglobin and blood 
cell counts. Phytochemical screening of the study plants revealed that 
alkaloids were found to be common in all of them.               
 Conclusion: It can be concluded that C.arientinum, C.verum and 
C.aurantifolin can be promising antidiabetic drugs with a great safety and no 
side effects. This verifies the traditional use of these plants as 
hypoglycaemic agents. 
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  اﻻﻃﺮوﺣﺔ
ﻟﻘﺪ هﺪف هﺬا اﻟﺒﺤﺚ ﻟﺪراﺳﺔ اﻷﺛﺮ اﻟﻤﻀﺎد ﻟﻤﺮض اﻟﺴﻜﺮى  ﻓﻰ اﻟﻤﺴﺘﺨﻠﺼﺎت    :اﻷهﺪاف  
 اﻟﻮﻳﺴﺘﺮ  ﺟﺮذاناﻟﻤﺎﺋﻴﺔ واﻟﻜﺤﻮﻟﻴﺔ ﻟﺒﺬور ﻧﺒﺎت اﻟﻜﺒﻜﺒﻴﻪ، ﻟﺤﺎء ﻧﺒﺎت اﻟﻘﺮﻓﺔ وأوراق ﻧﺒﺎت اﻟﻠﻴﻤﻮن ﻓﻰ
  . اﻟﺒﻴﻀﺎء اﻟﻨﺎﺿﺠﺔ
ﺮى ﻣﻌﻤﻠﻴﺎ ﺑﺎﺳﺘﺨﺪام ﺟﺮﻋﺔ ﻣﺜﻘﻠﺔ ﻣﻦ ﺗﻢ اﻧﺸﺎء اﻟﻨﻮع اﻟﺜﺎﻧﻰ ﻣﻦ ﻣﺮض اﻟﺴﻜ:    ﻣﻨﻬﺠﻴﺔ اﻟﺒﺤﺚ         
اﻟﺴﻜﺮ ﺑﻴﻨﻤﺎ أﻧﺸﺊ اﻟﻨﻮع اﻷول ﻣﻦ ﻣﺮض اﻟﺴﻜﺮى ﺑﺎﺳﺘﺨﺪام ﻣﺎدة اﻟﺴﺘﺮﻳﺒﺘﻮزوﺗﻮﺳﻴﻦ ﻓﻰ اﻟﺘﺠﻮﻳﻒ 
وﻗﺪ اﺗﺒﻊ اﺧﺘﺒﺎر ﺗﺤﻤﻞ اﻟﺠﻠﻮآﻮز ﻟﻤﺘﺎﺑﻌﺔ ﻣﺴﺘﻮى اﻟﺴﻜﺮ ﺑﻌﺪ اﻋﻄﺎء ﺟﺮﻋﺎت . ﺠﺰذاناﻟﺒﻴﺮﻳﺘﻮﻧﻰ ﻟﻠ
ﻴﺔ  اﻟﺪﻣﻮﻳﺔ ﺧﻠﻒ آﺮة اﻟﻌﺒﻦ، ﻟﻘﻴﺎس وﻗﺪ ﺟﻤﻌﺖ ﻋﻴﻨﺎت اﻟﺪم ﻣﻦ آﺘﻠﺔ اﻷوﻋ. ﻣﺴﺘﺨﻠﺼﺎت اﻟﻨﺒﺎﺗﺎت
هﻨﻴﺎت اﻟﺜﻼﺛﻴﺔ، وذﻟﻚ ﺑﺎﺳﺘﻌﻤﺎل اﻧﺎﺑﻴﺐ ﺷﻌﺮﻳﺔ ﺗﺤﺘﻮى ﻋﻠﻰ ﺪاﻟﻜﻮﻟﻴﺴﺘﺮول واﻟ، ﻣﺴﺘﻮى اﻟﺠﻠﻮآﻮز
ﻋﻴﻨﺎت اﻟﺪم آﻞ ﺳﺎﻋﺔ ﻟﻤﺪة أرﺑﻌﺔ ﺑﺎﻟﻨﺴﺒﺔ ﻟﻠﻨﻮع اﻟﺜﺎﻧﻰ ﻣﻦ ﻣﺮض اﻟﺴﻜﺮى ﻓﻘﺪ ﺟﻤﻌﺖ .اﻟﻬﻴﺒﺎرﻳﻦ
وﺗﻢ اﺧﺘﻴﺎر  . ﺳﺎﻋﺎت ﺑﻴﻨﻤﺎ ﺟﻤﻌﺖ ﻋﻴﻨﺎت اﻟﺪم ﻟﻠﻨﻮع اﻷول آﻞ أرﺑﻌﺔ ﺳﺎﻋﺎت ﻟﻤﺪة اﺛﻨﻰ ﻋﺸﺮ ﺳﺎﻋﺔ
اﻟﻘﻠﻴﺒﻨﻜﻼﻣﺎﻳﺪ آﺪواء ﻗﻴﺎﺳﻰ ﻣﺮﺟﻌﻰ ﻟﻠﻨﻮع اﻟﺜﺎﻧﻰ ﻣﻦ ﻣﺮض اﻟﺴﻜﺮى ﺑﻴﻨﻤﺎ أﺧﺘﻴﺮ اﻻﻧﺴﻮﻟﻴﻦ آﺪواء 
أﺛﺮ اﻟﺴﻤﻮم ﻓﻰ هﺬﻩ اﻟﻨﺒﺎﺗﺎت ﻋﻦ ﻃﺮﻳﻖ و اﺿﺎﻓﺔ اﻟﻰ ذﻟﻚ ﻓﻘﺪ ﺗﻢ اﺳﺘﻜﺸﺎف  .ﻗﻴﺎﺳﻰ  ﻟﻠﻨﻮع اﻷول
دراﺳﺔ أﺛﺮهﻢ ﻋﻠﻰ وﻇﺎﺋﻒ اﻟﻜﺒﺪ، وﻇﺎﺋﻒ اﻟﻜﻠﻰ، اﻟﻬﻴﻤﻮﻗﻠﻮﺑﻴﻦ، ﻋﺪد آﺮﻳﺎت اﻟﺪم اﻟﺒﻴﻀﺎء واﻟﺤﻤﺮاء 
  . وأآﺜﺮ ﻣﻦ هﺬا ﻓﻘﺪ ﺗﻢ ﻣﺴﺢ ﻋﺎم ﻟﻠﻤﻜﻮﻧﺎت اﻟﻜﻴﻤﻴﺎﺋﻴﺔ ﻟﻬﺬﻩ اﻟﻨﺒﺎﺗﺎت
ﻔﺾ ﻣﺴﺘﻮى ﺳﻜﺮ وأوﺿﺤﺖ  اﻟﻨﺘﺎﺋﺞ أن آﻞ اﻟﻨﺒﺎﺗﺎت أﻓﺼﺤﺖ ﻋﻦ أﺛﺮ واﺿﺢ ﻓﻰ ﺧ :  اﻟﻨﺘﺎﺋﺞ     
أﻣﺎ ﻧﺎﻟﻨﺴﺒﺔ ﻟﻠﻨﻮع اﻟﺜﺎﻧﻰ ﻓﻘﺪ أﺣﺮز ﻣﺴﺘﺨﻠﺼﻰ ﻧﺒﺎت اﻟﻘﺮﻓﺔ اﻷﺛﺮ اﻷآﺜﺮ أهﻤﻴﺔ اﺣﺼﺎﺋﻴﺔ . اﻟﺪم
 ﻓﻰ ﺧﻔﺾ ﻣﺴﺘﻮى ﺳﻜﺮ اﻟﺪم ﻃﻮال ﻓﺘﺮة اﻟﺘﺠﺮﺑﺔ ﻣﻘﺎرﻧﺔ ﻣﻊ ﻣﺠﻤﻮﻋﺔ اﻟﻀﺒﻂ واﻟﺪواء )100.0≤P(
ﻤﺴﺘﺨﻠﺺ اﻟﻤﺎﺋﻰ أﻣﺎ ﺑﺎﻟﻨﺴﺒﺔ ﻟﻠﻨﻮع اﻷول ﻣﻦ ﻣﺮض اﻟﺴﻜﺮى، ﻓﻘﺪ أوﺿﺢ اﻟ. اﻟﻤﺮﺟﻌﻰ اﻟﻘﻠﻴﺒﻴﻨﻜﻼﻣﺎﻳﺪ
ى اﻟﺴﻜﺮ ﻓﻰ اﻟﺪم واذى ﺑﺪأ ﻣﻨﺬ اﻟﺴﺎﻋﺔ اﻻوﻟﻰ، ﺑﻴﻨﻤﺎ ﻮﻟﻨﺒﺎت اﻟﻜﺒﻜﺒﻪ ﻣﻔﻌﻮل ﻣﺒﻜﺮ ﻓﻰ ﺧﻔﺾ ﻣﺴﺘ
 ﻓﻰ ﻣﺴﺘﻮى اﻟﺴﻜﺮ ﻓﻰ اﻟﺴﺎﻋﺔ )100.0≤P(أوﺿﺢ ﻧﺒﺎﺗﻰ اﻟﻘﺮﻓﺔ واﻟﻠﻴﻤﻮن اﻧﺨﻔﺎض ذو أهﻤﻴﺔ اﺣﺼﺎﺋﻴﺔ 
ﻟﺪواء اﻟﻤﺮﺟﻌﻰ اﻟﺜﺎﻧﻴﺔ واﻟﺮاﺑﻌﺔ ﺑﻌﺪ ﺗﻌﻠﻄﻰ ﺟﺮﻋﺎت اﻟﻤﺴﺘﺨﻠﺼﺎت، ﻣﻘﺎرﻧﺔ ﻣﻊ ﻣﺠﻤﻮﻋﺔ اﻟﻀﺒﻂ وا
أﻣﺎ ﺑﺎﻟﻨﺴﺒﺔ ﻷﺛﺮ هﺬﻩ اﻟﻨﺒﺎﺗﺎت ﻓﻰ ﺧﻔﺾ ﻣﺴﺘﻮى اﻟﺪهﻮن ﻓﻰ اﻟﺪم ﻟﺪى اﻟﻨﻮع اﻟﺜﺎﻧﻰ ﻣﻦ . اﻻﻧﺴﻮﻟﻴﻦ
ﻓﻘﺪ أوﺿﺢ اﻟﻤﺴﺘﺨﻠﺺ اﻟﻜﺤﻮﻟﻰ ﻟﻨﺒﺎت اﻟﻜﺒﻜﺒﻴﻪ اﻧﺨﻔﺎض ذو أهﻤﻴﺔ اﺣﺼﺎﺋﻴﺔ . ﻣﺮض اﻟﺴﻜﺮ
ﺔﻟﻠﻨﻮع اﻷول أﻣﺎ ﺑﺎﻟﻨﺴﺒ.  ﻓﻰ ﻣﺴﺘﻮى اﻟﻜﻮﻟﻴﺴﺘﺮول واﻟﺪهﻮن اﻟﺜﻼﺛﻴﺔ ﻃﻮال ﻓﺘﺮة اﻟﺘﺠﺮﺑﺔ)100.0≤P(
ﻣﻦ ﻣﺮض اﻟﺴﻜﺮﻓﻘﺪ ﺧﻔﺾ ﻣﺴﺘﺨﺎﺻﻰ ﻧﺒﺎت اﻟﻴﻤﻮن، اﻟﺪهﻮن اﻟﺜﻼﺛﻴﺔ اﻧﺨﻔﺎض ذو أهﻤﻴﺔ اﺣﺼﺎﺋﻴﺔ 
VX 
اﻣﺎ ﻓﻴﻤﺎ ﻳﺘﻌﻠﻖ ﺑﺎﻟﺪراﺳﺔ اﻟﺴﻤﻴﺔ ﻟﻬﺬﻩ اﻟﻠﻨﺒﺎﺗﺎت ﻓﻠﻢ ﺗﻮﺿﺢ اﻟﺪراﺳﺔ أى .  ﻣﻨﺬ اﻟﺴﺎﻋﺔ اﻷوﻟﻰ)100.0≤P(
ﻮﺑﻴﻦ، ﻋﺪد آﺮﻳﺎت اﻟﺪم وﻇﺎﺋﻒ اﻟﻜﺒﺪ، وﻇﺎﺋﻒ اﻟﻜﻠﻰ، اﻟﻬﻴﻤﻮﻗﻠﺗﻐﻴﻴﺮﻓﻰ اﻟﻤﺴﺘﻮى اﻟﻄﺒﻴﻌﻰ ﻓﻰ آﻞ ﻣﻦ 
 اﻟﻜﻴﻤﻴﺎﺋﻴﺔ ﻟﻨﺒﺎﺗﺎت اﻟﺪراﺳﺔ وﺟﻮد ﻣﺎدة اﻷﻟﻜﺎﻟﻮﻳﺪس ﻤﻜﻮﻧﺎتﺎ ﻟاﻣﺎ ﻓﻴﻤﺎ ﻳﺘﻌﻠﻖ ﺑ . اﻟﺒﻴﻀﺎء واﻟﺤﻤﺮاء
  .آﻌﻨﺼﺮ ﻣﺸﺘﺮك ﻓﻰ آﻞ ﻣﻦ ﻧﺒﺎت اﻟﻜﺒﻜﺒﻴﻪ اﻟﻘﺮﻓﺔ وأوراق اﻟﻠﻴﻤﻮن
 ﺗﻜﻮن ﻳﺴﺘﺨﻠﺺ ﻣﻦ هﺬﻩ اﻟﺪراﺳﺔ أن ﻧﺒﺎﺗﺎت اﻟﻜﺒﻜﺒﻴﻪ، اﻟﻘﺮﻓﺔ واﻟﻠﻴﻤﻮن ﻳﻤﻜﻦ أن :         اﻟﺨﻼﺻﺔ
هﺬا ﻳﺆﻳﺪ . أدوﻳﺔ واﻋﺪة ﻣﻀﺎدة ﻟﻤﺮض اﻟﺴﻜﺮى، ذوات ﻣﺄﻣﻮﻧﻴﺔ ﻋﺎﻟﻴﺔ و ﻟﻴﺲ ﻟﺪﻳﻬﻢ أﺛﺎر ﺟﺎﻧﺒﻴﺔ
 .  اﻻﺳﺘﻌﻤﺎل اﻟﺒﻠﺪى ﻟﻬﺬﻩ اﻟﻨﺒﺎﺗﺎت آﻌﻮاﻣﻞ ﺧﺎﻓﻀﺔ ﻟﻤﺴﺘﻮى اﻟﺴﻜﺮ ﻓﻰ اﻟﺪم
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Chapter One 
 
Literature Review 
1. Introduction: 
The use of herbs and medicinal plants in treatment of different 
diseases is as old as man himself. Mankind in ancient ages depended 
totally in treatment of diseases by herbs and medicinal plants, but this 
vanished gradually with urbanization of life-style except in very few 
areas of the world. With the spread of civilization, herbs and medicinal 
plants were gradually replaced by drugs and medicines of a chemical 
nature. With time a majority of recent drugs exfoliated many undesirable 
side effects and severe complications which may be more dangerous than 
the target disease itself. Furthermore, chemical drugs are relatively more 
expensive. Such disadvantages of modern drugs, caused mankind to refer 
again to the old use of herbs and medicinal plants in treatment of a variety 
of diseases including diabetes mellitus. For a long time, diabetes have 
been treated orally with several medicinal plants (Aktar and Ali 
1984).Synthetic hypoglycaemic agents can produce serious side effects 
and are not suitable for use during pregnancy (Laner 1985). Therefore, 
the search for more effective and safer hypoglycaemic agents has 
continued to be an important area of active research .Investigations on 
hypoglycaemic agents from medicinal plants has become more important 
(WHO expert committee, 1980).  
 Being a very large country with different climatic conditions, 
ranging from very dry deserts to very damp forests, Sudan is very rich in 
a vast variety of medicinal plants. Many  Sudanese tribes , specially the 
western tribes , depend almost totally  on  herbal treatment for  many 
diseases including diabetes  mellitus  , which is  one of the most  famous 
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and widely spreading  diseases . The records conducted by the National  
Center For Health Statistics in 1996 revealed  that 0.3% of the population 
of Sudan are suffering from diabetes mellitus with mortalities reaching up 
to 4.1% .This is encouraging to researchers to undergo studies in this field 
, so as to confirm and develop such traditional treatments . From the list 
of Sudanese hypoglycaemic plants, Cicer arientinum and Citrus 
aurantifolin are chosen for this study in addition to Cinnamomum verum 
which is an Indian plant. They are recorded as traditional hypoglycaemic 
agents but no pervious scientific studies were found to justify 
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1.1. Some world- wide reviewed hypoglycaemic medicinal plants:  
Acasia  arabica 
Aloe  vera 
Anacardium  occidentale 
Artemisia  dracuncuus 
Artemisia  herba  alba 
Azadirachta  indica 
Baphia  nitda 
Bidens  pilosa  
Boerhaavia  diffusa 
Caralluma  edulis  
Carum  carvi 
Catharanthus  roseus 
Cissus  sicyoides  
Coccinia  indica  
Cogniauxia  podoleana  Baillon 
Cyclocarya  paliurus  
Eucalyptus  globules  
Eugenia  jambolama 
Ferula  persica 
Fraxinus  excelsior  
Gongronema. latifolim 
Guazuma  ulmifolia, 
Gulnar  farsi, 
Gum  alibanum, 
Gum  assafooetida 
Gymnema  sylvestre 
Hydrastis  Canadensis 
Inula  racemosa, 
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Kola acuminata, 
Lepechinia  caulescens, , 
Loranthus  micranthus 
Marrubium vulgare, 
Mominda  lucida   
 Momordica  charantia  
Momordica  cyambalaria 
 Musa  sapientum, 
Nigella  sativa 
Ocimum  sanctum 
Opuntia  Streptacantha  
Paronychia  argentea, 
Psacalium peltatum 
Punica  granatum  
Rhizophora mangle   
Rubus  imperialis 
Sclerocarya  birrea 
Scoparia  dulcis 
Silybum marianum 
Tinospora  cordifolia 
Tinospora  crispa 
Trichosanthes kirilowi, 
Trigonella  foenum  graceam 
Tuner diffusa 
Viscum  album 
Zizyphus mauritiana  
Zizyphus sativa 
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Table(1-1) Sudanese Hypoglycaemic Medicinal Plants 
Folkloric 
Use
Chemical 
constituent 
Habitat  Family Latin nameEnglish 
Name
Arabic 
Name
Treatment 
of 
dermatitis,
eczema, loss 
of hair,T.B. 
and 
diabetes 
mellitus  
Glycosides, 
flavonoides, 
alkaloids and 
saponin
Wide 
spread in 
low lands  
Cucurbitaceae  Citrullus 
colocynthis
Bitter 
apple, 
Vine of 
sodon
  
لﻅﻨﺤﻟﺍ  
Nephritis, 
renal 
calculi. The 
leaves are 
used for 
treatment of 
diabetes 
mellitus  
Protein, 
carbohydrates, fat, 
and amino acid.  
North and 
central 
Sudan  
Asteraceae  Ambrosia 
maritime
Damsisa
  
ﺔﺴﻴﺴﻤﺩﻟﺍ
For 
treatment of 
calculi. and 
 diabetes 
mellitus  
Anthraquinone and 
Barbaloin  
Various 
areas  
Loaceae  Hardeuvulgare 
L.
Barley   ﺭﻴﻌﺸﻟﺍ
ﻯﺩﻠﺒﻟﺍ  
Removal of 
pyrexia, 
pains of 
colon and 
for 
treatment of 
diabetes 
mellitus  
Volatile oil, Sulpher 
compounds, 
vitamins and 
peptides.
  
Desert  Liliaceae  Aloe Spp  .............
....  
ﺭﺎﺒﺼﻟﺍ  
Treatment 
of hyper- 
tension, 
wounds 
cholesterol 
and anti 
diabetic  
Glycosides,flavonid
-es, steroids and 
saponin  
Various 
areas   
Liliaceae  Allium sativa L.Garlic  ﻡﻭﺘﻟﺍ  
Treatment 
of colic, 
diabetes 
mellitus and 
locally for 
treatment of 
measles. 
Protein, 
carbohydrates, fats, 
amino acid Volatile 
oil, alkaloids and 
saponins.  
low lands 
Wide 
spread in 
Northern 
Sudan  
Asclepiadaceae  Solenostemma 
argel
Argel  لﺠﺭﺤﻟﺍ
For 
treatment of 
flavonoides,alkaloid
s, saponin and 
Various 
areas  
Fabaceae  Trigonella 
foenum-
Fenugreek
, Greek 
ﺔﺒﻠﺤﻟﺍ  
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abdominal 
pain, 
diarrhoea, 
dysentery 
and 
diabetes 
mellitus.  
vitamins  graecum L.clover
  
Renal 
calculi and 
diabetes 
mellitus  
Rotenone,coumarin, 
glactoside and 
steroids  
Various 
areas  
Papilionoideae  Medicago 
sativum
Alfa alfa  ﻡﻴﺴﺭﺒﻟﺍ  
For 
treatment of 
diabetes 
mellitus  
Glycosides and 
flavonides  
low lands  Balanitaceae  Balaniteae 
egyptica
Desert 
date  
ﺞﻴﻠﺠﻬﻟﺍ  
The 
maceration 
of the leaves 
used for 
treatment 
ofD.mellitus 
 diabetes 
mellitus  
Glycosides and 
flavonides.  
low lands  Caesplpiniacecea
-e  
Bauhinia 
rufescens
Kulkul  لﻜﻠﻜﻟﺍ  
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:Diabetes mellitus-2-1 
 Diabetes mellitus is a clinical syndrome characterized by 
hyperglycaemia due to absolute or relative deficiency of insulin 
(Christopher, et al 2002).The hyperglycaemia is usually accompanied by 
glycosuria (Whitby, et al 1990). 
1-2-1-Epidemiology: 
 Diabetes is world-wide in distribution and its incidence is rising. In 
the year 2000, 150 million people world-wide had diabetes, and this is 
expected to double by 2010. This involves type II principally 
(Christopher-H, et al; 2002).  It is estimated that over 13 million people 
in the United States suffer from diabetes and that 650,000 new cases are 
diagnosed every year. Most diabetics (over 90%) have non-insulin 
dependent diabetes mellitus (NIDDM) or type II (Burke, et al., 1999)                                  
1-2-2-Predisposing Factors:  
 Increased longevity, obesity, unsatisfactory diet, sedentary lifestyle 
and increasing urbanaization (Christopher-H, et al; 2002). 
1-2-3-Types Of Diabetes mellitus : 
Diabetes manifests itself through abnormally high glucose levels 
and comes in two major forms: 
(a) Insulin dependent (typeI) 
(b) Non – insulin – dependent (type II) (Ford and Earl 2002). 
1-2-3-1-TypeI (Insulin dependent diabetes mellitus, IDDM): 
This usually presents acutely in young, non-obese subjects, but it 
can occur at any age. In general, insulin is required for treatment and 
ketosis is liable to occur.  
1-2-3-2-TypeII (Non –insulin – dependent diabetes mellitus, 
NIDDM):  
This type may be subdivided into non-obese and obese categories. 
It usually presents less acutely than type I, mainly in older (over 40 years 
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old), obese subjects. Insulin is not required to prevent ketosis as these 
patients are relatively resistant to the development of ketosis, but it may 
be needed for correction of abnormalities of glucose (Whitby., et al 
1990). 
1-3-Insulin:  
 It is a peptide hormone synthesized by the beta cells of the 
pancreas. Its inactive form, pro-insulin, is formed from A and B chains 
connected by a connecting peptide (C- peptide). This pro-insulin 
molecule folds and A and B chains become linked by disulphide bridges 
forming the active hormone insulin. The beta cells then contain insulin 
and C – peptide which split off with every unit formation of insulin. Since 
C-peptide has a longer half – life in plasma than insulin, it is sometimes 
measured as index of endogenous insulin secretion (Whitby. et al1990). 
1-4-Normal Glucose Metabolism: 
 Blood glucose is tightly regulated by homeostasis within a narrow 
range of 3.5-6.5 mmol/L. (64-118 mg/dl). When intestinal glucose 
absorption declines between meals, hepatic glucose output is increased in 
response to counter regulatory hormones glucagons and adrenaline and it 
falls during prolonged starvation as fats become more important as fuel. 
The liver produces glucose by gluconeogenesis and glycogen breakdown. 
Insulin is the only anabolic hormone and it has profound effects on the 
metabolism of carbohydrates, fats and proteins. It is secreted from 
pancreatic beta-cells in response to a rise in blood glucose. It lowers 
blood glucose by suppressing hepatic glucose production and stimulating 
peripheral glucose uptake in skeletal muscles and fat, mediated by the 
glucose transporter, GLUT4. Adipocytes and the liver, synthesize 
triglycerides (from non- esterified fatty acids (NEFAs) and glycerol). 
Insulin stimulates lipogenesis and inhibits lipolysis, so preventing fat 
catabolism. Lipolysis, mediated by triglyceride lipase, is stimulated by 
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catecholamine and liberates NEFAs, whose partial oxidation in the liver 
provides energy to drive gluconeogenesis and also produce ketone bodies 
(acetoacetate, which can be reduced to 3-hydroxybutrate or 
decarboxylated to acetone). Ketone bodies are organic acids which (in 
small amounts) are oxidized and utilized as metabolic fuels .The rate of 
utilization of ketone bodies by peripheral tissues is limited, and when the 
rate of production by the liver exceeds their removal, hyperketonaemia 
results. Ketogenesis is regulated by the supply of NEFAs reaching the 
liver and is therefore enhanced by insulin deficiency and release of the 
counter regulatory hormones that stimulate lipolysis (Christopher., et al 
2002).  
The important metabolic sites that are sensitive to insulin include 
the liver, where glycogen is synthesized, stored and broken down; 
skeletal muscles, where glucose oxidation produces energy; and adipose 
tissues, where glucose may be converted to fatty acids(Christopher., et al 
2002) (Erict, 1992). 
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Table (1-2): Metabolic Actions of Insulin 
 
Anabolic Effects (increased) Catabolic effects (decreased) 
Carbohydrate metabolism Carbohydrate metabolism
*Glucose transport (muscle and 
adipose tissues) 
*Glucose phosphorylation  
*Glycogenesis  
*Glycolysis 
*Pyruvate dehydrogenase activity 
*Pentose phosphate shunt 
*Gluconeogenesis. 
*Glycogenolysis. 
Lipid metabolism Lipid metabolism
*Triglyceride synthesis. 
*Fatty acid synthesis (liver). 
*Lipoprotein lipase activity 
(adipose tissues).
*Lipolysis. 
*Lipoprotein lipase (muscle). 
Protein metabolism Protein metabolism
*Amino acid transport
*Protein synthesis
*Protein degradation.*
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1-2-4- Metabolic Disturbances in Diabetes: 
 Insulin deficiency causes disturbance in carbohydrate, lipid and 
protein metabolism: 
1-2-4-1- Carbohydrate metabolism:  
Insulin deficiency leads to decreased glucose uptake by tissue, decreased 
glucose oxidation, increased gluconeogenesis and increased 
glycogenolysis. (Whitby. et al1990) 
1-2-4-2- Protein metabolism:-  
Anorexia and vomiting in uncontrolled diabetes interfere with 
orderly replacement in the daily turn over of body pool. Excess plasma 
cortisol, exert protein catabolic effect and interfere with amino acid 
incorporation to protein and thus become the source of gluconeogenesis, 
thereby contributing both to the hyperglycemia and ultimate loss of 
nitrogen from body (Ahuja 1983). 
1-2-4-3- Disturbance in fat metabolism:-  
Adipose tissue is most sensitive to insulin action therefore  low 
insulin activity is capable of suppressing fat storage and enhancing 
lipolysis .Fatty acid liberated from lipolysis in addition to being  
metabolized by liver in to ketone bodies ,can also be re-esterified  and 
packaged  in to VLDL .Further more, insulin  deficiency  cause  a 
decrease in lipoprotein lipase, the enzyme responsible for hydrolysis of 
VLDL  triglycerides in preparation  for  fatty acids storage in  adipose 
tissue (Christopher., et al 2002). 
1-2-5- Diagnosis Prior to 1997 diabetes was suspected if an individual 
had at least two fasting glucose readings of 140 mg/dl (7.8 mmol/L) on 
two separate occasions. In 1997 the American Diabetes Association 
lowered the diabetes cut-off point to 126 mg/dl (7 mmol/L) on two 
separate occasions. So now the rules are: 
• Fasting glucose level less than 110 mg/dl is considered normal 
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• Fasting glucose level between 110 and 126 mg/dl indicates 
impaired glucose tolerance (insulin resistance) 
Fasting glucose level at or above 126 mg/dl indicates diabetes, (Expert 
committee 2002) 
1-2-5-1-Indications for oral glucose tolerance test: 
.Fasting plasma glucose 6.1-6.9 mmol/l. 
.Random plasma glucose 7.0-11.0 mmol/l. 
N.B. HbA1C is not for diagnosis. 
1-2-5-2-Oral Glucose Tolerance Test (OGTT)  
a) Fasting plasma sample is taken after overnight fast (8-12 hours). 
b) Then patient is given 75 grams glucose orally. 
c) Plasma and urine glucose concentrations are determined in fasting and 
at 30 minutes intervals for 3 hours after glucose ingestion. (Whitby. et 
al1990).  
1-2-5-2-1- Interpretation of the results of OGTT: 
• 2-hour reading of less than 140 mg/dl (7.8 mmol/L) is normal 
• 2-hour reading of between 140 and 200 mg/dl is indicative of 
impaired glucose tolerance  
• 2-hour reading of 200 mg/dl or greater is indicative of diabetes. 
The National Institutes of Health recommends that diabetes should be 
suspected only if at least two readings in the 2- hour period are equal to 
or greater than 200 mg/dl (Expert committee 2002). There is evidence 
that food intake during the two days prior to the glucose tolerance test can 
materially affect the results. It is best to eat a diet rich in complex 
carbohydrates and avoid an excessive intake of protein and fats (Whitaker 
and Julian 2001). 
1-5-Glycated haemoglobin (A1C): 
 Glycated haemoglobin provides an accurate measure of glycaemic 
control over a period of weeks to months. This can be utilized as an 
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assessment of glycaemic control in a patient with known diabetes, but is 
not sufficiently sensitive to make a diagnosis of diabetes and is usually 
normal in patients with impaired glucose tolerance. (Christopher., et al 
2002). Glycated haemoglobin is formerly named glycosylated 
haemoglobin (Whitby. et al1990). Haemoglobin A1C is the major 
haemoglobin in adults (97%). Normally, about 5-8 % of haemoglobin A1C 
reacts none enzymatically with glucose to form glycated haemoglobin or 
HbA1C. This remains over the life span of RBCs (120 days). The 
concentration of glycated haemoglobin is directly proportional to the 
glucose level over the life span of RBCs (Arise of 1 % in Hb A1C 
corresponds to an approximate average increase of 2 mmol/l of blood 
glucose. (Christopher, et al 2002). In diabetes mellitus with uncontrolled 
hyperglycaemia, glycated haemoglobin will be 12 % or more high. 
1-6-1-Importance of Hb A1C : 
It is used as an index of diabetic control over 2-3 months .It correlates 
with the mean plasma glucose concentration during this period. The 
higher the percentage, the poorer the mean diabetic control (Whitby. et 
al1990). 
 1-2-6- Complications of diabetes:  
The most serious problem with high glucose levels is that the excess 
glucose tends to bind to proteins and cause them to become ‘sticky’. This 
process is called glycosylation and is a major factor in atherosclerosis and 
other diabetes complications. The higher than normal insulin levels 
(hyperinsulinaemia) experienced by people with insulin resistance or type 
II diabetes is also highly detrimental. They interfere with the normal 
metabolism of fats and cause an increase in the production of very – low 
– density cholesterol, a potent risk factor of heart disease. High insulin 
levels also encourage the formation of blood clots and thereby increase 
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the risk for heart attacks. Finally, High insulin levels can lead to 
hypoglycaemia (low blood sugar level). 
Long-term, uncontrolled high blood sugar levels can lead to a number of 
serious complications; among them are kidney failure, hypertension, 
diabetic retinopathy (eye disease) neuropathy (nerve disease), heart 
disease, peripheral vascular disease (intermittent claudication), stroke and 
diabetic foot disease. (Whitaker and Julian 2001).  
1-2-7- Guide lines to therapy:-  
         All patients with diabetes require diet therapy .Good glycaemic 
control is unlikely to be achieved with insulin or oral therapy when diet is 
neglected, especially when the patient is also over weight (Christopher., 
et al 2002). 
1-2-7-1-Management of Diabetes: 
Three methods of treatment are available: 
1- diet alone 
2- oral hypoglycaemic drugs  and 
3- Insulin. 
All patients with diabetes require diet therapy .Good glycaemic 
control is unlikely to be achieved with insulin or oral therapy when diet is 
neglected, especially when the patient is also over weight (Christopher., 
et al 2002).  
-Approximately 50 % of new cases of diabetes can be controlled 
adequately by diet alone.  
-20-30 % will need an oral hypoglycaemic drug and  
-20-30 % will require insulin. 
The ideal management of diabetes would allow the patient to lead a 
completely normal life. 
Diet, exercise and oral hypoglycaemic agents are the mainstay of 
conventional treatment of insulin resistance and type II diabetes 
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(Whitaker and Julian 2001).The diet emphasizes the avoidance of simple 
sugars and an increased intake of fiber (Bernstein., et al 1997). 
Exercise helps to reduce insulin levels and lowers cholesterol and 
triglyceride levels as well as blood pressure (Spelsberg., et al 1995). 
Many patients with insulin resistance or type II diabetes can actually 
revert to a non-diabetic state just by exercising and following a proper 
diet (Murray., et al 1998). 
1-2-7-2- Diet for insulin – treated diabetes:  
An insufficient dose of insulin for a meal with a large carbohydrate 
content leads to post – prandial hyperglycaemia, while inadequate 
carbohydrate consumption risks hypoglycaemia.  
A useful meal-planning tool is the plate model which encourages the 
inclusion of carbohydrate as the main part of the meal in conjunction with 
vegetables, and limits the consumption of protein – containing foods. 
(Christopher., et al 2002). 
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1-2-7-2- Diet for insulin – treated diabetes:  
Fig. (1-1)  
 
         
1-2-7-2-1- Oral hypoglycaemic drugs: 
 There are various, and although their mechanisms of actions are 
different, most depend upon a supply of endogenous insulin and they 
therefore have no hypoglycaemic effects in patients with type I diabetes. 
1-2-7-2-1-1-Combined Oral Hypoglycaemic Therapy and Insulin: 
  In diabetic patients who are requiring increasing doses  of 
sulphonylurea or biguanide  , either alone  or in combination with each 
other or with a thizolidinedione  ,  the introduction  of a single dose of an 
intermediate – acting  insulin (usually isophane),  administered at 
bedtimes may improve glycaemic control and delay pancreatic beta cell 
failure . The exogenous insulin suppresses hepatic glucose output during 
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the night and lowers fasting blood glucose. This treatment is ineffective 
in diabetic  patients  who  have  no  residual  endogenous   insulin i.e. (C-
peptide –negative). For patients who are approaching secondary failure to 
oral medication, this provides a single and effective introduction to self-
treatment with insulin with little risk of hypoglycaemia (Christopher., et 
al 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 18
Table (1-3): Oral Hypoglycaemic Agents  
Drug Mechanism of action Indications Dose Side effects
Sulphnylureas
Tolbutamide,
Chlorpropamide 
Glibenclamide ,
Glimepiride
.Stimulate release of 
insulin (insulin 
secretagogues).
.reduce hepatic 
gluconeogenesis.
For non –obese patients 
with type II diabetes.
Increase in weight.
Biguanides
Metformin
.increase insulin 
sensitivity and 
peripheral glucose 
uptake.
.impairs glucose 
absorption by the gut. 
For obese patients as it is 
not associated with a rise 
in body weight.
500-1 g,
(12-
hourly).
GIT symptoms.
Contraindicated:
In patients with impaired 
renal or hepatic function 
and in alcohol 
addicts.(risk of lactic 
acidosis) 
Alpha-Glucoside 
Inhibitors
Acarbose, 
moiglitol.
.delay carbohydrate 
absorptions in the gut 
by selectively 
inhibiting 
disaccharides.
.lower post-prandial 
blood glucose 
.improve overall 
glycaemic control.
Good for obese patients. Taken 
with each 
meal.
Flatulence, abdominal 
blooting and diarrhoea.
Thiazolidinedion
(TZD)
Glitazone ,
Rosoiglitazone,
Pioglitazone
 
.enhance the action of 
endogenous insulin 
(mainly in adipose 
tissue).
Indicated for patients 
with insulin resistance.
Should be 
prescribed 
with either 
a 
sulphonyl
ureas or 
metformin
Weight gain and fluid 
retension.
Contraindicated:
In people with cardiac 
failure. 
Meglitinides
Repaglinide
.regulate prandial 
glucose.
For non obese patients. Immediate
ly before 
Increase body weight.
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Nateglinide. .stimulate endogenous 
insulin secretion
food  and 
prescribed 
with 
metformin 
 
1-2-7-2-1-2-Side effects of some oral hypoglycaemic drugs: 
Sulphonylureas have the potential for many quite serious side 
effects. Among the more common are hypoglycaemia, weight gain, 
gastrointestinal problems, and hypothyroidism and skin rashes. They also 
increase the risk of heart disease and circulatory problems (Whitaker and 
Julian 2001). 
Metformin (Glucophage) and thiozolidinediones, have the potential for 
some very serious side effects such as increase in blood pressure, increase 
in heart diseases, lactic acidosis, weight gain, increase in low – density – 
cholesterol and liver damage (Whitaker 2001). 
The potentially devastating side effects of these drugs can be completely 
avoided by replacing them with natural supplements (Whitaker 2001).  
1-2-3-6- Experimental diabetes:- 
Specific cytotoxic agents such as alloxan or streptozotocin can 
selectively destroy the β-cell of the pancreas. Injection of these agents 
produces a form of chemical diabetes, which closely resembles diabetes 
due to surgical removal of the pancreas. Streptozotocin is abroad-
spectrum antibiotic with anti-tumor and oncogenic properties which is 
widely used as a diabetogenic agent  in experimental animals..This action 
is mediated by beta-cell destruction, which results in the development of 
an insulin-dependant syndrome (Rakieten, et al; 1963 and Herr., et al 
1967).  
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1-2-3-7- A Survey on the anti-diabetic activity of some medicinal 
plants: 
Recently, many experimental and clinical trials were adopted to 
detect the hypoglycemic and anti diabetic effects of many medicinal 
plants used in the folk medicine for the treatment of diabetes mellitus. 
1-2-3-7- 1- Experimental studies on laboratory animals 
Acetone extraction of seeds of Trigonella foenum graceam 
exhibited a dose related hypoglycaemic effect on cadmium or alloxan –
induced hyperglycaemic rats. The induced hyperglycaemia was 
antagonized by the acetone extracts of the seed, stem and leaves of 
Trigonella foenum. These extracts appear to act at the cellular level to 
produce hypoglycaemic effects on normal and cadmium or alloxan – 
induced hyperglycaemic rats. (Ghafghazi., et al 1977). 
Among a mixture of five plants in used by Kwaiti diabetics only the 
Myrrh and aloe gums effectively increased glucose tolerance in both 
normal and diabetic rats. The remaining components, Gum alibanum, 
Nigella sativa seeds and Gum assafooetida were without effect (Al-
Awadi and Gumaa 1987). 
Petroleum ether extracts of Inula racemosa, lowered plasma insulin and 
glucose levels within 75 minutes of oral administration to albino rats and 
it significantly counteracted adrenalin –induced hyperglycaemia. All 
these findings indicate that one of the constituents of Inula racemosa may 
have adrenergic beta blocking activity (Tripathi., et al 1988). 
Oral administration of an aqueous extract of the aerial parts of 
Artemisia herba alba to normoglycaemic and to alloxan –diabetic  
rabbits, produced significant hypoglycaemic activity which was 
consistent and time dependent (Twaij and Al Badr 1988). 
An aqueous decoction of the aerial part of Teucrium hyperglycaemic rats 
indicated a significant reduction in blood glucose concentration 4 hours 
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after intravenous administration and 24 hours after intaperitoneal 
administration. This effect could be due to enhancement of peripheral 
glucose metabolism rather than an increase in insulin release (Gharaibeh 
., et al, 1988). 
Although the extract of Cassia alata has no effect on glucose levels 
in normoglycaemic animals, it reduced blood sugar value in 
streptozotocin-induced hyperglycaemic animals (Palanichamy ., et al 
1988). 
A single 0.5 ml oral dose of 40-80 % decoctions of Trigonella 
foenum graceum to normal as well as alloxanized mice was followed by 
hypoglycaemia developed over a 6-hour period. Reduction in blood 
glucose concentration was highly significant, and was maximum at 6 
hours. It was dose-dependent. The hypoglycaemia caused by ethanol 
extract (200-400 mg/kg) in alloxanized mice was also dose-dependent 
and 200 mg/kg was comparable in effect to 200 mg/kg of Tolbutamide 
(Ajabnoor and Tilmisany 1988). 
The powdered seeds of Acasia Arabica act by initiating the release 
of insulin from pancreatic beta cells of normal rabbits.Moreover, 
Caralluma edulis did not show any hypoglycaemic effect in normal as 
well as in diabetic rabbits (Wadood ., et al, 1989). 
A hypoglycaemic effect due to an aqueous extract of Tinospora 
crispa stems was observed in moderately diabetic rats with concomitant 
improvement in insulinaemia. After a two- weeks treatment with the 
extract in drinking water, these rats also showed improvement in glucose 
tolerance. Moreover, acute intravenous treatment caused an increase in 
plasma insulin levels. The data support that. Tinospora crispa extract 
improves diabetic conditions by virtue of its action on the endocrine 
pancreas (Noor and Ashcroft 1989). 
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No seasonal variation in the hypoglycaemic activity of Opuntia 
Streptacantha Lemaire was detected, suggesting it can be used year round 
for treatment of Diabetes mellitus (Meckes ., et al 1989). 
Momordica charantia Linn plant, Coccinia indica whit, Arm root 
and Tricosanthes dioica Roxb, significantly lowered blood sugar in fasted 
model and depressed the peak value in glucose loaded models 
(Chandrasekar ., et al 1989). 
Single (100-400 mg/kg) oral doses of an alcoholic extract of 
Zizyphus sativa leaves to normal rats showed a dose-dependent 
statistically significant lowering of blood glucose 2, 4 and 6 hours later. 
The effect was most pronounced at 6 hours with glucose returning to 
control values at 24 hours. In alloxan-diabetic rats, no significant effect 
was observed (Anamd ., et al 1989). 
A traditional treatment for diabetes mellitus, consisting of seven 
plants and a herbal mixture was given a 6.5 % by weight of the diet of 
streptozotocin diabetic mice for 9 days. The results suggest that bearberry 
(Arctostaphylos uva – ursi); golden seal (Hydrastis canadensis), mistletoe 
(Viscum album) and tarragon (Artemisia dracuncuus) may counter some 
of the symptoms of diabetes mellitus such as hyperplasia and polydipsia 
without affecting glycaemic control (Swanston and Flatt  1989). 
The non- dialyzable portion of the water extract of the Oriental 
crude drug (Karokon), the roots of Trichosanthes kirilowi, was fond to 
reduce the plasma glucose level in mice. Five glycan termed as trichosans 
A, B, C, D, and E were isolated from this drug. The main glycan, 
trichosan, also exhibited activity in alloxan – induced hyperglycaemic 
mice (Hikino., et al1989). 
Among twelve plants used for treatment of diabetes mellitus only 
Guayusa and mushroom retarded the development of hyperglycaemia in 
streptozotocin diabetic mice and reduced the hyperphagia, polidipsia, 
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body weight loss and glycated haemoglobin. Mushroom also countered 
the initial reduction in plasma insulin and the reduction in pancreatic 
insulin concentration and improved the hypoglycaemic effect of 
exogenous insulin. These studies suggest the presence of potentially 
useful anti-diabetic agents in guayusa and mushroom (Swanston and Flatt 
1989). 
Twenty eight medicinal plants used in the treatment of diabetes 
mellitus were studied for their anti-hyperglycaemic effect. Each plant was 
processed in the traditional way and intragastrically administered to 
temporarily hyperglycaemic rabbits. The results showed that 8 out of 28 
studied plants significantly decreased the hyperglycaemic peak and / or 
the area under the glucose tolerance curve. The plants were: 
Guazuma ulmifolia, Tournefoctia hirsutissima, Lepechinia caulescens, 
Rhizophora mangle, Musa sapientum, Trigonella foenum graceum, 
Tunera diffusa and Euphorbia prostrate. The results suggest the validity 
of their clinical use in diabetes control, after their toxicological 
investigation (Alarcon and Aguilaria  ., et al 1998). 
Eucalyptus globules (eucalyptus) are used as a traditional treatment 
for diabetes. In this study, incorporation of eucalyptus in the diet (62.5 
g/kg) and drinking water (2.5 g/L) reduced the hyperglycaemia and 
associated weight loss of streptozotocin-treated mice. An aqueous extract 
of eucalyptus (0.5 g/L) enhanced 2- deoxy –glucose transport by 50 %, 
glucose oxidation by 60 % and incorporation of glucose into glycogen by 
90 % in mouse abdominal muscle. Within 20 minutes aqueous extract of 
eucalyptus evoked a stepwise (70-160 %) enhancement of insulin 
secretion from the clonal pancreatic beta-cell line. These data indicate 
that Eucalyptus globulus represents an effective antihyperglycaemic 
dietary adjustment for the treatment of diabetes and a potential source for 
 24
discovery of new orally active agent(s) for future therapy (Gray and Flatt 
1998). 
The protective effect of Anacardium occidentale aqueous extract 
against streptozocin – induced diabetes was evaluated in rats. The rats 
were treated with 175 mg/kg of the extract per os, twice daily, beginning 
2 days before streptozotocin (STZ) injection. A total of 3 days after STZ 
administration, there was a 48% increase in blood glucose level in pre-
treated rats, compared with an increase in diabetic control rats treated 
with STZ alone. Furthermore, these pre-treated animals presented no 
glycosuria, a normal weight gain and a non significant increase in food 
and fluid intake at the end of the treatment compared with the normal 
control. Diabetic control animals showed a positive glycosuria, body 
weight loss, a real polyphagia and polydypsia. These results indicate the 
protective role of Anacardium occidentale extract against the 
diabetogenic action of STZ (Kamtchouing ., et al 1998). 
The hypoglycaemic and anti – hyperglycaemic activities of 
methanol extract of Mominda lucida Benth. Leaves were studied in 
normal and streptozotocin (STZ) – diabetic rats .In normal rats, the 
extract demonstrated a significant (P<0.05) and dose–dependent 
hypoglycaemic activity within 4 hours after oral administration. After 12 
hours, the plasma glucose level of rats administered 50, 100, 200 or 400 
mg/kg of extract also decreased. In hyperglycaemic rats, the extract 
produced a significant (P< 0.05) anti – diabetic effect from day 3 after 
oral administration, with 400 mg/kg extract –treated animals having a 
plasma glucose level of 248.7+5.3 mg/100ml compared with 
glibenclamide (10 mg/kg ) with plasma level of 251.5 + 5.8 mg/100 ml 
.These results suggest that the leaves of Morinda lucida have a strong 
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glucose lowering property when administered to STZ –treated rats 
(Olajide ., et al 1999). 
This study was undertaken to investigate the effect of Momordica 
cyambalaria fruit powder on blood glucose and other biochemical 
parameters in alloxan – induced diabetic rats. The treatment was given for 
15 days. After the treatment, a significant reduction was observed in 
fasting blood glucose levels in the treated diabetic rats, but no 
hypoglycaemic activity in the treated normal rats. Momordica 
cyambalaria treatment showed considerable lowering of serum 
cholesterol and triglycerides in treated diabetic group. There was a 
significant improvement in hepatic level after the treatment with the 
M.cymbalaria. These results suggest that the Momordica cyambalaria 
fruit powder possesses ant diabetic and hypolipidemic effects in alloxan –
induced diabetic rats (Rao 1999).  
The aqueous extract of the leaves of Zizyphus mauritiana Lam 
(Rhamnaceae) was studied for its antidiabetic effect. The extract was 
administered per os to Wistar rats made diabetic either temporarily by 
oral glucose tolerance test (first case) or definitely by subcutaneous 
injection of alloxan (second case). It was observed a striking decrease of 
the hyperglycaemic arrow (p<0.05) in the first case, with 300mg/kg 
administered 90 minutes before starting the test. In the second case , the 
results obtained with a dose of 300 mg/kg once or twice a day were 
identical as those with glibenclamide at 0.2 mg/kg per day .So , the 
antidiabetic activity of Zizyphus mauritana Lam. was experimentally 
born out but it has to be standardized for common use (Cisse ., et al 
2000). 
Gulnar farsi, male abortive flowers of Punica granatum L. was 
used for the treatment of diabetes mellitus in Unani medicine. Oral 
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administration of its aqueous – ethanol extract led to significant blood 
glucose lowering effect in normal, glucose-fed hyperglycaemic and 
alloxan-induced diabetic rats. This effect of the extract was maximum at 
400 mg/kg body weight (Jafri ., et al 2000). 
The hypoglycaemic effect of five Brazilian medicinal plants was 
studied on alloxan-induced diabetic rats. The extract of these plants were 
intragastrically administered to diabetic rats. The results showed that all 
plant studied (except one) significantly lowered the blood glucose. These 
results suggest that these four medical plants could be an adjuvant agent 
in the treatment of diabetes mellitus. The four plants were Marrubium 
vulgare, Rubus imperialis and Wedelia poludosa (Novaes ., et al 2001). 
Hypoglycaemic activity was detected in dichloromethane methanol 
extract (111) of leaves and twigs of Catharanthus roseus (family 
Apocynaceae) a traditionally used medicinal plant using streptozotocin 
(STZ) induced diabetic rat model. Extract at dose 500 mg/kg given orally 
for 7 and 15 days showed 48.6% and 57.6% hypoglycaemic activity, 
respectively. Prior treatment at the same dose for 30 days provided 
complete protection against STZ challenge (75 mg /kg /I.P. X I). Enzymic 
activities of glycogen synthase, glucose-6-phosphate–dehydrogenase, 
succinate dehydrogenase and malate dehydrogenase were decreased in 
liver of diabetic animals and were significantly improved after treatment 
with extract at dose 500 mg/kg / p.o. for 7 days. Results indicate 
increased metabolization of glucose in treated rats. Increased levels of 
lipid peroxidation measured as 2-thiobarbituric acid reactive substances 
indicative of oxidative stress in diabetic rats were also normalized by 
treatment with the extract (Singh., et al 2001).  
This study was executed to evaluate the anti-diabetic potency of a 
polyherbal formulation, and its influence on derangement in metabolism 
of glucose, cholesterol and sodium levels in normal and alloxan induced 
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diabetic rats. Serum glucose and cholesterol were found to be increased in 
diabetic animals. Serum sodium as well as urinary sodium, hepatic 
glycogen were found to be decreased in diabetic state .Treatment with the 
polyherbal formulation (1.0 ml/kg body weight) for 30 days in diabetic 
animals has shown decrease in serum glucose and serum cholesterol 
levels in comparison to control animals, whereas in normal treated 
animals, the formulation does not affect the serum glucose and serum 
cholesterol levels. Serum sodium and urinary sodium levels were 
increased in both diabetic treated and the control animals. Hepatic 
glycogen levels were increased in diabetic treated animals, but there was 
no change in the control treated animals (Annapurna ., et al 2001).  
In the past 15 years, there have been controversial reports on the 
hypoglycaemic activity of Aloe species, probably due to difference in the 
parts of the plant used or to the model of diabetes chosen .In the study, 
separate experiments on three main groups of rats, namely non-diabetic 
type I (IDDM) and type II (NIDDM) diabetic rats were carried out. Aloe 
Vera leaf pulp and gel extracts were ineffective on lowering the blood 
sugar level of non diabetic rats. Aloe vera leaf pulp extract showed 
hypoglycaemic activity on IDDM and NIDDM rats, the effectiveness 
being enhanced for type II diabetes in comparison with glibenclamide. 
On the contrary, Aloe vera leaf gel extract showed hyperglycaemic 
activity on NIDDM rats .It may therefore be concluded that the pulps of 
Aloe vera leaves devoid of the gel could be used in treatment of non-
insulin dependent diabetes mellitus (Okyar ., et al 2001). 
The purpose of this study was to investigate the effects of daily 
oral feeding Momordica charantia (Mc) (200mg/kg) , Eugenia 
jambolama (200 mg/kg) , Mucuna pruriens (200 mg/kg) and Tinospora 
cordifolia extracts for 40 days on blood glucose concentrations and 
kidney functions in (STZ)-diabetic rats . Plasma glucose levels, body 
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weight, urine volume and urinary albumin levels were monitored on 
every 10 days over a 40- day’s period, while plasma creatinine levels 
were assessed at the beginning and end of the experiment.  Renal 
hypetrophy assessed the ratio between the kidney weight and total body 
weight. Plasma glucose concentrations in STZ–diabetic mice were 
reduced by the administration of extracts of Momordica charantia , 
Tinospora cordifolia , and Mucuna pruriens by 24.4 , 20.84 , 7.45 and 
9.o7 % , respectively, (P<0.005) for Momordica charantia, Eugenia 
jambolama ,MP and (P 0.05) for Tinospora cordifolia) . Urine volume 
was significantly higher (P<0.005) in diabetic control and Momordica 
charantia, Eugenia jambolama, MP and TC treatment prevented polyuria 
(P < 0.001, 0.0001 0.01 and 0.001 respectively).After 10 days of STZ 
administration on urinary albumin level (UA) were over 6 folds higher in 
diabetic controls as compared to normal controls. Treatment with 
Momordica charantia, Eugenia jambolama, Mucuna pruriens and 
Tinospora cordifolia significantly prevented the rise in (AU) levels from 
day 0 to 40 in comparison to diabetic controls (P<0.0001, 0.0001, 0.005 
respectively). Renal hypertrophy was significantly higher in diabetic 
controls as compared to non-diabetic controls. Tinospora cordifolia and 
MP failed to modify renal hypertrophy. Results indicate that these plant 
drugs should be studied further (Grover ., et al 2001). 
The hypoglycemic activities of four water ethanol extracts (WEE) 
prepared from Bidens pilosa L., Salvia officinalis L., Psacalium peltatum 
H.B.K. (Cass) and Turnera diffusa Wild. Were investigated in healthy 
and alloxan-diabetic mice. The WEE of S. officinalis significantly 
reduced the fasting blood glucose of normal mice. The WEE of P. 
peltatum and B. pilosa also significantly diminished glycemia in healthy 
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mice. In mildly diabetic mice, the WEE of Psacalium. peltatum lowered 
the basal blood glucose level. The WEE of Bidens pilosa and Salvia 
officinalis also significantly diminished the hyperglycemia in mildly 
diabetic mice. The administration of these three extracts to animals with 
severe hyperglycemia did not cause a significant decrease. The WEE of 
Turnera. diffusa did not show any hypoglycemic activity. Thus, three of 
the WEE studied conserved the hypoglycemic activity originally detected 
in the traditional preparations of the studied antidiabetic plants. It appears 
that these extracts require the presence of insulin to show hypoglycemic 
activity (Alarcon and Aguilar 2002). 
Gongronema latifolim is a rain forest plant, which has been 
traditionally used in the south eastern part of Nigeria for the management 
of diabetes. The effects of oral administration of aqueous and methanolic 
extracts of the leaves of Gongronema. latifolim for 2 weeks to STZ   
induced diabetic rats were investigated. Results suggest that the extracts 
from Gongronem .latifolium leaves could exert their anti-diabetic 
activities through their anti-oxidant properties (Ugochukwu ., et al 2002). 
          This study was undertaken to examine the hypoglycemic effect of 
aqueous extract of Hypoxis hemerocallidea (family: Hypoxidaceae) corm 
(locally known as "African Potato") in normal (normoglycemic) and in 
streptozotocin (STZ)-treated, diabetic rats., the results of this 
experimental animal study indicate that African potato possesses 
hypoglycemic activity; and thus lends credence to the suggested folkloric 
use of the herb in the control and/or management of adult-onset, type 2 
diabetes mellitus in some communities of South Africa. (Mohamed ., et al 
2003). 
This study examined the hypoglycemic activity of Cyclocarya 
paliurus (Batal.) Iljinskaja in mice by oral glucose tolerance testing. The 
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blood glucose level was significantly lower in the C. paliurus extract 
treatment group than in the control group (Kurihara ., et al 2003). 
        To unravel the possible mechanism of glucose lowering activity, 
effects of ten different plant extracts in the regulation of serum cortisol 
and glucose concentrations were evaluated in male mice. While the 
extracts of Inula racemosa, Boerhaavia diffusa and Ocimum sanctum 
decreased the serum concentration of both cortisol and glucose, Aegle 
marmelos, Azadirachta indica and Gymnema sylvestre extracts could 
exhibit hypoglycaemic activity without altering the serum cortisol 
concentration. It appears that the hypoglycaemic effects of former three 
plant extracts are mediated through their cortisol inhibiting potency, 
whereas the mechanism for other plant extracts could be different. Lipid-
peroxidation was not enhanced by any of the plant extracts (some were in 
fact, antiperoxidative in nature). As Inula racemosa, Boerhaavia diffusa 
and Ocimum. sanctum exhibited antiperoxidative, hypoglycaemic and 
cortisol lowering activities, it is suggested that these three plant extracts 
may potentially regulate corticosteroid induced diabetes mellitus 
(Gholap., et al 2004). 
The hypoglycemic effect of aqueous extracts of Carum carvi and 
Capparis spinosa L. (CS) fruit were investigated in normal and 
streptozotocin (STZ) diabetic rats. After administration of the aqueous 
Carum carvi and CS extracts produced a significant decrease on blood 
glucose levels in STZ diabetic rats the blood glucose levels were nearly 
normalized 2 weeks after daily repeated oral administration of both 
aqueous Carum carvi and Capparis spinosa L.  extracts. No highly 
significant changes on blood glucose levels were noticed in normal rats 
after both acute and chronic treatments with Capparis spinosa L.  and 
Carum carvi. In addition, no changes were observed in basal plasma 
insulin concentrations after treatment with these plants in either normal or 
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STZ diabetic rats indicating that the underlying mechanism of this 
pharmacological activity seems to be independent of insulin secretion. 
We conclude that aqueous extracts of Carum carvi and Capparis spinosa 
L.  exhibit a potent anti-hyperglycaemic activity in STZ rats without 
affecting basal plasma insulin concentrations (Eddouks ., et al 2004). 
Cissus sicyoides (Vitaceae) is a medicinal plant popularly known in 
Brazil as "cipo-puca, anil-trepador, cortina, and insulina". The plant is 
used in treatment of diabetes. In the present work. The hypoglycemic and 
anti-lipedemic effects of the aqueous extract prepared from fresh leaves 
of the plant were studied in the model of alloxan-induced diabetes in rats. 
The Results showed that the daily treatment of diabetic rats with aqueous 
extract prepared from fresh leaves of Cissus sicyoides for 7 days 
significantly decreased blood glucose levels, a significant decrease was 
observed in plasma triglyceride levels (Viana ., et al 2004). 
The effect of an aqueous extract of Origanum vulgare (OV) leaves 
on blood glucose levels was investigated in normal and streptozotocin 
(STZ) diabetic rats. In normal rats, the blood glucose levels were slightly 
decreased 6 hrs after a single oral administration of the aqueous extract 
produced a significant decrease on blood glucose levels in STZ diabetic 
rats (P<0.001) (Lemhadri ., et al 2004). 
The hypoglycemic effect of the aqueous extracts of Fraxinus 
excelsior seeds and Silybum marianum aerial part was investigated in 
normal and streptozotocin (STZ) diabetic rats. After a single dose or 15 
daily doses, oral administration of the aqueous extracts (20 mg/kg) 
produced a significant decrease of blood glucose levels in both normal 
and STZ diabetic rats (P < 0.001). From the first week, the body weight 
was increased in normal rats (P<0.05) and decreased in STZ rats (P<0.01) 
after FE administration. In addition, no changes were observed in basal 
plasma insulin concentrations after both FE and SM treatments in either 
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normal and STZ diabetic rats indicating that these plants exert their 
pharmacological activity without affecting insulin secretion. It is 
concluded that the aqueous extracts of Fraxinus excelsior and Silybum 
marianum exhibit potent hypoglycemic and anti-hyperglycemic activities 
in normal and STZ rats, respectively, without affecting basal plasma 
insulin concentrations (Maghrani .,  et al 2004). 
The fruit of Tetrapleura tetraptera (Taub) [Fabaceae] is frequently 
used in Tropical African traditional medicine for the management and/or 
control of diabetes mellitus. The present study was undertaken to 
examine the hypoglycemic effects of Tetrapleura tetraptera (Taub) fruit 
aqueous extract in rats. Streptozotocin (STZ)-induced diabetes mellitus 
was used as an experimental test model of diabetes. The plant extract 
produced dose-dependent, significant reductions (P < 0.05 - 0.001) in the 
blood glucose concentrations of both fasted normal and fasted diabetic 
rats. The results of this experimental animal study indicates that 
Tetrapleura tetraptera fruit aqueous extract possesses anti-inflammatory 
and hypoglycemic properties. These findings lend pharmacological 
credence to the suggested folkloric uses of the plant's fruit in the 
management and/or control of arthritis and other inflammatory 
conditions, as well as in adult-onset, type-2 diabetes mellitus in some 
Yoruba-speaking communities of South-Western Nigeria (Ojewole., et al 
2004). 
This study indicates that the crude methanolic extract of Loranthus 
micranthus (Linn.) exhibited statistically significant hypoglycemic and 
anti-hyperglycemic activities in normoglycemic and alloxan-induced 
diabetic albino rats. 
The methanolic extract of African mistletoe was found to be a good 
candidate for alternative and/or complimentary medicine in the 
management of diabetes mellitus. The leaves of the Eastern Nigerian 
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species of the African mistletoe harvested from Kola acuminata, 
Azadirchta indica and Baphia nitda host trees exhibited comparatively 
better anti-hyperglycemic activities among the host trees studied( 
Osadebe ., et al 2004). 
In order to appraise some of the ethno medical uses of Sclerocarya 
(A. Rich.), this study was undertaken to investigate the analgesic, anti-
diabetic properties of the plant's stem-bark aqueous extract in 
experimental models of diabetes mellitus. The analgesic effect of 
Sclerocarya birrea stem-bark aqueous extract was evaluated in mice while 
anti-diabetic effects were investigated in rats. The results of this 
experimental animal study indicate that Sclerocarya birrea stem-bark 
aqueous extract possesses analgesic and hypoglycemic properties 
(Ojewole 2004). 
 In this study, the preventative anti-diabetic and anti-obese effects 
of wild Ginseng (a shade-loving herb) ethanol extract (WGEE) were 
investigated. In the preventive experiment, WGEE co-administered with a 
high fat diet significantly inhibited body weight gain, fasting blood 
glucose, triglyceride, and free fatty acid levels in a dose dependent 
manner. WGEE-treated mice at doses of 250 and 500 mg/kg improved 
the insulin resistance index by 55% and 61% compared to the high fat 
diet control, respectively. Diameters of white and brown adipocytes were 
also decreased by 62% and 46% in the WG500-treated group compared 
to those in HFD fed control mice. Taken together, wild Ginseng  ethanol 
extract (WGEE)  has potential as a preventive agent for type 2 diabetes 
mellitus (and possibly obesity) and deserves clinical trial in the near 
future (Yun.,  et al 2004). 
The hypoglycemic effect of Ganoderma lucidum polysaccharides 
(Gl-PS) was investigated in the normal fasted mice. It is found that Gl-PS 
possesses the hypoglycemic effect on normal mice through its insulin-
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releasing activity due to a facilitation of Ca2+ inflow to the pancreatic beta 
cells (Zhang., et al 2004). 
Cogniauxia podoleana Baillon leaves are used in Congolese 
traditional medicine for the treatment of diabetes mellitus. Based on an 
increasing number of reports on blood glucose level reduction associated 
with some saponins and flavonoids isolated from medicinal plants, the 
hypoglycemic and antihyperglycemic effects of flavonoid and saponin 
fractions were investigated (Diatewa ., et al 2004). 
Ferula persica, Paronychia argentea, and Pistacia atlantica are 
three of the plants widely recommended by the herbalists and used for 
their hypoglycemic activity in Jordan. Aqueous extracts of these plants 
were tested in vitro for their hypoglycemic activity in normoglycemic and 
streptozocin-induced hyperglycemic rats. Although the three plants were 
advocated for their hypoglycemic effects in Jordanian traditional herbal 
medicine; none of them showed significant hypoglycemic activity 
compared to the untreated animals (Hamdan., et al 2004). 
Oral administration of the aqueous extract of Scoparia dulcis plant 
extract to diabetic rats led to decreased levels of blood glucose and 
plasma glycoproteins. The levels of plasma insulin and tissue sialic acid 
were increased whereas the levels of tissue hexose hexokinase and 
fructose were near normal. This study indicates that S.dulcis possesses a 
significant beneficial effect on glycoproteins in addition to its antidiabetic 
effect (Latha and Pari 2005). 
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1-2-3-8- Hypoglyacemic Medicinal Study Plants 
1-2-3-8-1-  Cicer arientinum 
1-2-3-8-1-1- Morphology: 
Erect shrubby quick-growing annual about 50 cm high, 
 
Photo (1-1): Cicer arientinum  
 
General taxonomy: 
ﻲﺒﻜﺒآ ﺺﻤﺤﻟا Arabic Name: 
English Name:    chick peagarbanza 
Latin name: Cicer arientinumL 
Family: Fabaceae 
Habitat: Northern Sudan 
1-2-3-8-1-2- Chemical constituent:  
Volatile oil, amino acids and starch. 
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1-2-3-8-1-3- Pharmacology: 
The active ingredient, Daphnethin, has an antibacterial activity on both 
gram-positive and gram – negative bacteria. Genistein has an antifungal 
activity. The seeds are stimulant and tonic, used in skin diseases and for 
nourshing hair and face (Harborne 1999). 
1-2-3-8-1-4- Toxicology: 
Cicer is edible and no adverse effects are reported from this plant 
(Harborne 1999) 
1-2-3-8-1-5- Folkloric Use:  
1-2-3-8-1-6- Treatment of obesity and diabetes mellitus(Elghazali et al, 
1994). 
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1-2-3-8-2- Cinnamomum verum 
1-2-3-8-2-1- Morphology: 
 It is a moderate sized tree. The bark is smooth, light pinkish brown 
and thin, with a strong, pleasant small and spicy, burning taste.   
Photo  (1-2): Cinnamomum verum   
 
1-2-3-8-2- 2- General taxonomy:  
ﺔﻓﺮﻘﻟاArabic Name:     
English Name:  Cinnamon, Ceylon cinnamon   
Latin name: Cinnamomum verum    
Family: Lauraceae  
Habitat: India 
1-2-3-8-2-3- Chemical constituent:  
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Volatile oil, cinnamic aldehyde and terpenoides. 
1-2-3-8-2-4-  Pharmacology: 
 The active ingredient on cinnamon turned to be water-soluble poly 
phenol compound called MHCP. This compound mimics insulin, 
activates its receptor, and works synergistically with insulin in cells. 
Cinnamon can improve glucose and cholesterol (Alam Khan 2003)  
1-2-3-8-2-5- Folkloric Use: 
Renal diseases, diabetes mellitus, productive cough, CNS stimulant, 
memory activator and menstural cycle stimulant. (Elghazali., et al 1994).  
The essential oil in Cinnamon has demonstrated strong antibacterial and 
antifungal properties (Bruneton 1995).Cinnamon bark has also shown 
strong lipolytic activity, hydrolysig fats (Leung and Foster 1996).  
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1-2-3-8-3 -Citrus aurantifolin 
1-2-3-8-3-1- Morphology: 
A spine scent tree up to 6 m in height.  
Photo (2-3): Citrus aurantifolin  
  
1-2-3-8-3-2- General taxonomy: 
نﻮﻤﻴﻠﻟا Arabic Name:  
English Name: Lime  
Latin name: Citrus aurantifolin 
Family: Rutaceae 
Habitat: Various areas 
1-2-3-8-3- 3- Chemical constituent: 
 Volatile oils, terpeins, hesperidin and vitamin B, citric acid, vitamin C, 
potassium and calcium citrate and flavinoides.  
1-2-3-8-3- 4- Folkloric Use: 
 The stem is used as an antiseptic for mouth, the juice is used for 
treatment of rhinitis and cold and can be added to coffee and tea for 
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treatment of diarrhoea, the boiled leaves can be used for treatment of 
diabetes mellitus. (Elghazali., et al,1994.  
1-6- Objectives: 
1-This study is carried out to confirm the folkloric use of Cicer 
arientinum, Cinnamomum verum and Citrus aurantifolin in treatment 
of diabetes mellitus. 
2-To determine the effectiveness of these plants as hypoglycaemic 
agents compared with known reference drugs as Glibenclamide for 
non insulin-dependent diabetes mellitus (NIDDM) and Insulin for 
Insulin –dependent diabetes mellitus (IDDM). 
3-To evaluate the effects of these plants on plasma total cholesterol 
and plasma triglyceride levels in (NIDDM) and on (IDDM). 
4-To evaluate the toxicity of these plants in terms of their effects on 
haematological parameters, biochemical parameters (Liver and 
Kidney function tests) and histopathological changes. 
5-To determine the pharmacological effects of these plants on isolated 
body tissues. 
6-To phytochemically screen these plants for their chemical 
constituents. 
7-To formulate these plants in suitable pharmaceutical forms to be 
used by diabetic patients as oral hypoglycaemic agents. 
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Chapter Two 
2- Materials and Methods   
2-1 Study area: 
The hypoglycaemic effect of the study plants in type II diabetic rats was 
studied at the research laboratory – Faculty of pharmacy – University of 
Khartoum, while that for type I, together with the toxicological study, 
were performed at the Medicinal and Aromatic Plants Research 
Institute (MAPRI) – National Centre for Researches (Khartoum).The 
biochemical analysis was carried out at The Diagnostic Research Unit 
(Khartoum Hospital).The histopathological investigation was conducted 
at the Histopathology laboratory – Faculty of Veterinary Medicine – 
University of Khartoum.  
2-2 The study plants: 
The experimental plants used in this study were the seeds of Cicer 
arientinum, the bark of Cinnamomum verum and the leaves of Citrus 
aurantifolin.  
2-2-1 Source of the study plants: 
C.arientinum and C.verum were obtained from Omdurman General 
Market while C.aurantifolin was obtained from a home-garden in  
Omdurman.  
 
 
 
 42
2-3.   The study animals:  
Photo (2-1): Group of Wistar Albino Rats.  
 
350 adult male Wistar albino rats, weighing 100-300 grams were used 
throughout the course of this study. 140 rats represented type II, 140 rats 
were used for type I and 70 rats were used for the toxicological study. All 
rats were obtained from the Faculty of Pharmacy; University of 
Khartoum. The diet given to the rats consisted of (meat + flour + milk + 
salt + oil) besides water ad libidum. 
2-3-1 Study groups: 
2-3-1-1 Controls:  
30 rats were distributed among 3 control groups of 10 rats each. One 
group represented the control for type I, another for type II and a third 
one for the toxicological study.  
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2-3-1-2 Standards: 
20 rats were distributed into two standard groups. The standard reference 
drug for type I, was Insulin and that for type II was Glibenclamide.  
2-3-1-3 Samples: 
2-3-1-3-1 Sample groups for Types II and I diabetes mellitus:  
In type I as well as type II, each of the plants was studied in terms of two 
extracts (aqueous and methanolic) and each extract was studied in terms 
of two doses (400 and 200 mg/kg). Thus 40 rats were used by each plant 
for each type; consequently the total number of rats used as samples for 
investigation of the ant diabetic effects of these plants was 240 rats.  
2-3-1-3-2 Samples for the toxicological study: 
This part dealt with the two doses of the methanolc extracts of the 3 study 
plants. Thus 60 rats were utilized. 
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2-4 Chemicals, reagents and Equipments:  
Table (2-1) Materials - Chemicals and reagents  
Chemicals  
2% hydrochloric acid             BDH chemical LTD; Poole, England
2% potassium Ferro cyanide BDH chemical LTD; Poole, England
Acetic anhydride                    E- Merch, Darmstadt A rt.42
Benzene (Benzol) E merch, Darmstadt, Art.1783.
Chloroform AR Analytical Rasyan
Concentrated sulphuric acid. Analytical Rasyan
Cristaseal Hawksley, England
DPX-mountant Avishkar, India
Eosin BDH chemical LTD; Poole, England
Ethanol BDH chemical LTD; Poole, England
Ethanol 80 %    Riedgl-DE. Haen AG SEELZE-
Hannover
Ethyl acetate. Analytical Rasyan
Ethylene diamine tetra acetic acid 
(EDTA)
Analytical Rasyan
Formal Saline (Haymes Solution). Analytical Rasyan
Formaldehyde Fisher Scientific Company; New Jersey
Glibenclamide                    Sigma, mixed anomer lot 74 F
Glucose 50% Analar  (AR)
Haematoxylin Sid-fine chem., India
Halothane BP ICI India Limited, Ennor, Chennai-
600 057.
Hydrochloric acid HCl 2N Analytical Rasyan
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Hydrogen peroxide 3% B.P. Bell Sons & Co. LTD; South Port 
PRQ 9AL, England.
Insulin (Soluble)                            
Methanol Analytical Rasyan.
n-hexane                   LOBA CHEMIE PVT. LTD.Mumbai-
400002 Ind
Paraffin wax Burgoyne-India, Mumbai
Petroleum ether                  E.Merck (India) Limited, Mumbai-400 
018.
Plant Extract (Aqueous and alcoholic)
Potassium hydroxide  0.5N  Scharlau Chemie S.A. ITD   England.
Sodium picrate paper (Picric acid) BDH Laboratory Supplies Poole, 
 BH 15 ITD, England.                            
Sodium sulphate anhydrous    Chadweil Health ESSEX-England.
Standard haemoglobin Cromatest-ISO 9001
Streptozotocin Sigma   S 0130.
Xylene Carlo erba, Milano
Kits 
Alkaline phosphatase kits Plasmatec Laboratory products LTD. 
Bridport, Dorset DT6 5BU. U.K.)
Cholesterol kits Plasmatec Laboratory products LTD. 
Bridport, Dorset DT6 5BU. U.K.
Creatinine kits Plasmatec Laboratory products LTD. 
Bridport, Dorset DT6 5BU. U.K.)
Glucose kits Plasmatec Laboratory products LTD. 
Bridport, Dorset DT6 5BU. U.K.
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GOT kits Plasmatec Laboratory products LTD. 
Bridport, Dorset DT6 5BU. U.K.)
GPT kits Plasmatec Laboratory products LTD. 
Bridport, Dorset DT6 5BU. U.K.)
Triglyceride kits Plasmatec Laboratory products LTD. 
Bridport, Dorset DT6 5BU. U.K.)
Urea kits Plasmatec Laboratory products LTD. 
Bridport, Dorset DT6 5BU. U.K.)
Reagents 
Diluting solution for total RBCs 3.8% w/v tri sodium citrate plus 5 
ml 10% formaldehyde were added 
to 495 ml of  Formal Citrate. 
Diluting solution for total WBCs 1.5ml glacial acetic acid and 1ml 
1% of an aqueous solution of 
gention violet were added to 98 ml 
of D.W. 
Drabkin`s solution for haemoglobin 0.2g potassium ferric cyanide &1g 
sodium bicarbonate were dissolved 
in 1 litre of D.W. 
Mayer’s reagent (1) 1.36 gm of Hgcl2 were dissolved 
in 60 ml distilled water (2) 5 gm of 
potassium iodide were dissolved in 
10 ml water; Solution (1) & (2) 
were  mixed and distilled water was 
added up to 100 ml). 
Vasler`s reagent 10 gm of potassium iodide was 
dissolved in 100 ml of water, and 
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then mercuric iodide was added 
until saturation. Excess mercuric 
iodide was removed. 
 
(Table 2-2) Equipments 
Equipment Source
Centrifuge MSE
Centrifuge tubes MSE
Centrifuge tubes / Centrifuge Hettich EBA 35 Werk-Nr, Baujahr
Freeze drier ALPHA-1-12 W.Germany.
Frosted one end side slide Schniewindt
Haematokrit capillary tubes
Microhaematokrit Centrifuge
SUPE-PIOR-Germany. Code No.4361
Hawksley & Sons Ltd., England.
Heparinized capillary tubes Supe-Rior-Germany, Code NO.4361 
Hotplate Herraeus (dehydrater)
Light microscope Olympus Optical.
Measuring cylinders (50ML) Volac
Microhaematokrit reader Hawksley, England.
Micropipettes 5-50 ul Volac 
Microscopic cover glass 24 x 50 mm Schniewindt
Microtome Medax
Neubauer haemocytometer ENM-England.
Oven used to melt wax Schniewindt
Oven used to melt wax Schniewindt
Pasteur pipettes Hettich EBA 35 Werk-Nr, Baujahr
Photographic microscope Leitz-Dialux 20
Rotatavapor BUCH1 011, Switzerland.
Rough balance  Sartorius 2351, Germany.
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Naso -gastric feeding tubes Ch/FR (8) Kawamoto Corporation 
 Osaka Japan.
Sample containers AFMA – DISPO.
SB water bath Fisher.
Sensitive balance HF-300G A&D Company, Limited.
Soxhlet apparatus Quick Fit, EX 5/83.England.
Spectrophotometer Jenway 6305 UV/Vis., Jenway LTD, 
UK
Spectrophotometer Jenway 6305 UV/VIS
Syringe s 5 ml/c Chunjee Medical Industry CO. Koria.  
Syringes 1 ml/cc NeojectNeomedic LTD-Middlesex U.K
Vacuum embedding oven Schniewindt
Water bath Fisher
Water bath. BUCH1 416 Switzerland.
Yellow tips Volac
 
2-5 Methods 
2-5-1 Plants:- 
2-5-1-1 Preparation of the aqueous extract: 
100 grams of the seeds of Cicer arientinum, 100 grams of the bark 
of Cinnamomum verum and 50 grams of the leaves of Citrus aurantifolin   
were weighed and each was just covered with boiling distilled water in a 
separate flask. They were incubated in a water bath at 60°c for four hours 
after which they were filterted. The filtrates were freez- dried. The dry 
powders were sealed in separate containers till use. 
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2-5-1-2 Preparation of the alcoholic extract:  
60 grams of each plant were weighed and packed in soxhlet 
apparatus.500 ml of petroleum ether was used as a solvent for each to 
separate lipids and terpenoids. The samples were then unpacked and left 
to dry. The same samples were repacked in soxhlet and Chloroform was 
used as a solvent for the same purpose (separate lipids and terpenoids). 
The samples were again unpacked, dried and repacked again, this time 
with   alcohol as a solvent to get the polar constituents of the plants. The 
extracts were evaporated till dryness using a rotatory evaporator, 
(Harborne 1999). 
2-5-1-3 Phytochemical screening:-  
A general screening was performed to identify the chemical 
constituents of the plants using the following methods. 
2-5-1-3-1 Preparation of the extract for the phytochemical screening:  
10 grams of the powdered tested part of the plants were refluxed 
with 100 ml of 80% ethanol in a round bottle flask for 4 hours. The cool 
solution was filtered and 80% ethanol was re-added to complete the 
filtrate to 100 ml. The prepared extract (PE) was used for the following 
standard  tests: 
2-5-1-3-2 Test for unsaturated sterols and triterpenses:- 
10 ml of the (PE) was evaporated to dryness on a water bath and 
the cooled residue was stirred several times with petroleum ether to 
remove most of the coloring materials. The residue was then extracted 
with 10 ml chloroform. The chloroform solution was dehydrated over 
sodium sulphate anhydrous. 5 ml portion of the chloroform solution was 
mixed with 0.5 ml of acetic anhydride followed by 2 drops of 
concentrated sulphuric acid. The gradual appearance of green , blue and 
pink to purple color was taken as an evidence for the presence of sterols 
(green to blue) and as triterpenses (pink to purple) in the sample. 
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2-5-1-3-3 Test for alkaloids: 
7.5 ml of the (PE) was evaporated to dryness on a water bath. 5 ml 
of 2N HCL was added and stirred while heating on the water bath for 10 
minutes, cooled, filtered and divided into two test tubes. To one test tube 
few drops of Mayer's reagent was added while to the other tube few drops 
of valser`s reagent was added. A slight turbidity as heavy precipitate in 
either of the two test tubes was taken as a presumptive evidence for the 
presence of alkaloids.  
2-5-1-3-4 Test for flavonoids:  
17.5 ml of (PE) was evaporated to dryness in a water bath, cooled 
and the residue was defatted by several extractions with petroleum ether 
and the defatted residue was dissolved in 30 ml of 80% ethanol and 
filtered. To 3 ml of the filtrate in a test tube, 1 ml of 1 % potassium 
hydroxide solution was added. A dark yellow colour indicated the 
presence of flavonoid compounds. 
2-5-1-3-5 Test for tannins:-  
For this test 7 ml of the (PE) was evaporated to dryness on water 
bath. The residue was extracted several times with n – hexane and 
filtered. The insoluble residue was stirred with 10 ml of hot saline 
solution .The mixture was cooled, filtered and the volume of the filtrate 
was adjusted to 10 ml with more saline solution. 5 ml of this solution was 
treated with few drops of gelatin salt reagent. Formation of immediate 
precipitate was taken as evidence for the presence of tannin in the plant 
sample. To another portion of this solution, few drops of ferric chloride 
test reagent were added. The formation of blue, black or green colour was 
taken as an evidence for the presence of tannins. 
2-5-1-3-6 Test for saponins: 
          I g of the original dried powder plant material was placed in a clean 
test tube. 10 ml of distilled water was added and the tube was stoppered 
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and vigorously shaken for about 30 seconds. The tube was then allowed 
to stand and observed for the formation of (honeycombs whose persistent 
appearance for at least an hour), was taken as an evidence for the 
presence of saponins. 
2-5-1-3-7 Test for cyanogenic glycosides: 
3 grams of the powdered plant sample was placed in an Erlenmeyer 
flask and sufficient water was added to moisten the sample, followed by 1 
ml of chloroform (to enhance every activity). A piece of freshly prepared 
sodium picrate paper was carefully inserted between a split cork which 
was used to stopper the flask .A change in color of the sodium picrate 
paper from yellow to various shades of red was taken as an indication of 
the presence of cyanogenic glycoside .                                      
2-5-1-3-8  Test for Anthraquinone glycoside:-  
1 gram of the powdered plant sample was boiled with 10 ml of 0.5 
N KOH containing 1ml of 3% hydrogen peroxide solution. The mixture 
was extracted by shaking with 10 ml of benzene and 5ml of the benzene 
solution was shaken with 3ml of 10% ammonium hydroxide solution and 
the two layers were allowed to separate. The presence of anthraquinone 
was indicated by pink and red colour. 
2-5-1-3-9 Test for coumarins: 
1 gram of the original powdered plant sample was boiled with 20 
ml distilled water in a test tube. A filter paper was attached to the test 
tube in order to be saturated with the vapor after adding to it 0.5N KOH, 
then the presence of cummarins was indicated if the spot was found to 
adsorb the UV light. 
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2-5-2 Animals 
Experiments performed in animals were three, two of which dealt 
with studying the hypoglycaemic effects of the three plants 
(C.arientinum, C.verum and C.aurantifolin) and one dealt with studying 
the toxicity of the target plants. 
2-5-2-1 Sample collection: 
         Blood samples were collected from the retro-orbital plexus of rats 
using heparinized capillary tubes (Khanna et al., 1992). This procedure 
was performed after anaesthetizing the rats through inhalation of 
halothane soaked in a piece of cotton bedded in a glass jar. 
Photo -2: Collection of blood samples from the Retro-Orbital Plexus 
of the rat's eye. 
 
2-5-2-2 Preparation of plasma: 
          Blood samples for measurement of glucose were collected into 
fluoride oxalate sample containers to prevent glycolysis, while blood 
samples for the other parameters (cholesterol, triglycerides, urea, 
creatinine, Na, K, GOT, GPT and ALP) were collected in heparinized 
sample containers and after mild shaking were centrifuged at 3000 
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revolutions/minute (rpm) for 15 minutes.  The fluid part (plasma) was 
separated from the cellular part using a dropper and the plasma was 
placed in a new plane sample container labeleds according to the study 
group, rat number, time and date of collection.  
2-5-2-3 Experimental design for the hypoglycaemic effect : 
The experimental design of this study was based on the known 
glucose tolerance test (GTT), , except that intraperitoneal route was used 
rather than the oral route, for very rapid intery of glucose into the blood 
circulation through the portal vein. This group represent a reversible type 
II (NIDDM) induced by an intra-peritoneal loading dose of 50% glucose 
at a dose of2g/kg body weight. 
2-5-2-3-1 Experimental procedure for the hypoglycaemic effect of the 
study plants in type II : 
 Animals were allowed to feed and drink ad libidum three days 
before the experiment. Then the target animals whether controls , 
standards or tests , were allowed to fast for eighteen hours by removal of 
all food materials except water. They were weighed and marked with 
serial numbers and the doses were calculated according to individual 
body weights. After the eighteen hours fast, blood samples were obtained 
from the retro orbital plexus (Khanna et al., 1992), using heparinized 
capillary tubes.  Samples were collected at 0, 1, 2 and 4 hours post 
dosing. The 0 time represented the fasting blood samples while the 2 
hours samples represented the post prandial sample. After collection of 
blood a calculated loading dose of glucose 2g /kg body weight of 50% 
glucose (konuklugil ., et al 1997) was given intraperitoneally (I/P) to each 
rat by means of (1ml Syringe). Simultaneously a dose of water 10 ml /kg 
body weight.  (Aguilar., et al 1993) was administered orally to control 
rats by means of a gastric tube. The time after administration of doses 
was noted. Blood samples for the 1, 2 and 4 hours were collected in the 
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same way. All samples were  centrifuged at 3000 revolutions per minute 
(3000 r.p.m) for 10 minutes after which plasma was separated from the 
cellular part of blood by means of Pasteur pipettes .The glucose 
concentration was immediately determined by means of plasmatic kits. 
The remaining plasma was kept freezed (till use) for the biochemical 
analysis of cholesterol and triglycerides. The some steps were followed 
for the standards and sample groups except that for the standard 
glibenclamide, 10 mg / kg .body weight   at a concentration of 2 mg /ml 
of water given orally instead of water. The sub groups of samples 
received two doses (200 and 400mg/kg.b.w) of the aqueous and alcoholic 
extracts of the study plants orally. 
2-5-2-3-2 Experimental procedure for the hypoglycaemic effect of the 
study plants in type I diabetic rats: 
The same steps were also followed except that this time type I 
diabetes mellitus was induced in rats by intraperitoneal injection of  
streptozotocin (STZ) at a dose of (60 mg / kg b wt), dissolved in citrate 
buffer at a concentration of  20mg /1ml to provide a pH of 4.5 (Rakieten 
et al 1963). 48 hours latter, blood glucose was determined and those who 
became diabetic were chosen for the study. 
 Soluble insulin at a dose of 3U/kg (diluted 100 times) was used as 
standard for type I diabetes mellitus (instead of glibenclamide). Samples 
were collected at 0, 4, 8 and 12 hours (Suba et al 2004).  
2-5-2-4 Experimental design for the toxicological study: 
A toxicological study was performed by studying the effects of the 
two doses of the alcoholic extracts on the blood haemogram as well as on 
the liver and kidney functions. Furthermore half the lethal dose (LD50) 
was determined. 
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2-5-2-4-1 Experimental procedure for the toxicological study:    
A sub-chronic toxicological study was performed for the three 
plants. The control group was given a dose of water from day (0) until 
day (21), while the tested groups were given 200 and 400 mg/kg /b.w. of 
the alcoholic extracts of C.arientinum, C.verum and C.aurantifolin 
respectively. Blood samples were collected at day (0) and day (21) for 
determination of blood haemogram (T.WBCs , T.RBCs &, Hb) liver 
function tests (Alanine amino transferase (ALT=GOT), Aspartate 
aminotransferase (AST=GPT) and Alkaline phosphatase (ALP)) and 
kidney function tests (urea, creatinine Na and K).The experimental rats 
were dissected at day (21)and their organs were cut in appropriate sizes 
and fixed in 10%formalin and then were used for histopathological 
investigation. 
Half the lethal dose (LD50) was determined for the study plants by oral 
administering of different doses of the extracts to experimental rats  until 
half the number of rats is dead. 
2-5-2-5 Experimental design for the Pharmacological study: 
A pharmacological screening was conducted in the rabbit intestine 
for determination of the effective dose and investigation of the 
mechanism of action of the study plants according to the method 
described by .Kitchen, 1984. 
2-2-2-6- Experimental procedure for histopathological study: 
The specimens were collected immediately after slaughtering and 
fixed in 10% formaldehyde, embedded in paraffin wax, sectioned at 5µm 
and stained. The sections were examined and photographed by a phase 
contrast microscope. The histopathological processing included fixation, 
dehydration, clearing, wax impregnation, section cutting, staining, 
examination and photographing by a phase contrast microscope, 
according to (Roy M. 1973). 
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2-2-2-6-1- The  staining process:  
               The staining process was performed using  Haematoxylin and 
eosin  according to Bancroft and Gumble, 2002. Light microscopic 
examinations were carried out at magnifications of 4 xs, 10 xs and 40 xs. 
According to Ustundag et al., 2000. 
2-2-2-7- Haematological Investigations: 
Red Blood Cells count (RBCs count), white blood cells count 
(WBCs count), and Haemoglobin concentration [Hb], were measured. 
Blood samples were collected into dry clean bottles; the anticoagulant 
was ethylene diamine tetra acetic acid (EDTA). 
2-2-2-7-1- Red blood cells (RBC) count: 
Total erythrocytes were counted according to the method described 
by Dacie 1998. 
2-2-2-7-2- Total White blood cells (TWBC) count: 
White cells were counted according to Lewis et al., 2001.     
2-2-2-7-3- Haemoglobin concentration [Hb]: 
The concentration of haemoglobin was measured by the 
cyanomethaemoglobin technique according to the method described by  
Dacie 1998 .  
2-2-2-8- Plasma Biochemical Analysis: 
2-2-2-8-1- Glucose Oxidase Method: 
the glucose concentration in blood,  was determined using kits 
according to the method described by Trinder 1969. 
2-2-2-8-2- Cholesterol Enzymatic Colorimetric Test: CHOD-PAP: 
It is an enzymatic method; for measuring total cholesterol 
concentration in the serum or heparinized plasma described by Richmond 
(1974), and Zoppi and Fellini (1976) using kit. 
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2-2-2-8-3- Triglyceride Enzymatic Test: 
The triglycerides are enzymatically hydrolyzed to glycerol as 
reported by Richmond (1974), and Zoppi and Fellini (1976) 
2-2-2-8-4- Glutamate Oxaloacetate Transaminase (GOT): 
=Aspartate amino transferase (AST): 
Plasma GOT activity was determined by colorimetric method, as 
described by Cheesbrough 1987. 
2-2-2-8-5- Glutamate Pyruvate Transaminase (GPT): 
= Alanine amino transferase (ALT): 
Plasma GPT activity was determined by colorimetric method, as 
described Karmen 1955 , using kit, 
2-2-2-8-6- Alkaline Phosphate (ALP): 
Alkaline phosphate activity was measured calorimetrically by a 
method similar to the procedure described by Chemie (1972). 
2-2-2-8-7- Creatinine Determination: 
Creatinine was determined by the method described by Slot (1965). 
2-2-2-8-8- Urea Determination: 
Plasma urea level was measured by the enzymatic method 
described by Marsh and Miller (1965), using kit. 
2-2-2-8-9-   Sodium Determination: 
Sodium was determined by the standard procedure of  flame 
emission spectrophotometry at 589nm. 
2-2-2-8-10-   Potassium Determination:  
Potassium was determined by the standard procedure of  flame 
emission spectrophotometry at 768nm. 
2-2-2-9-Statistical Analysis: 
Mean values in serum parameters were compared using the the 
SPSS - student’s t-test.  Data were expressed in mean ± standard error of 
mean (Mendenhall 1971). 
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2-2-2-10- Conversion of Animal Doses to Human Equivalent 
  Doses (HED): 
 The human equivalent dose was calculated for each plant 
extract according to the guidance prepared by the Office of New Drugs in 
the Centre for Drug Evaluation and Research (CDER) in cooperation with 
the Centre for Biologics Evaluation and Research (CBER) at the United 
States - Food and drug Administration, December 2002.  
2-2-2-10-1-Preparation of Antidiabetic Capsules of Cicer 
arientinum: 
The (HED) for C. arientinum was found to be 1gram, thus o.5 
grams of the completely dried alcoholic powdered extract was packed in 
(zero – size) gelatin capsules using the manual capsule machine. 2 
capsules are recommended to be taken by the diabetic patient per day, to 
correspond the HED. 
2-2-2-10-2-Preparation of Antidiabetic Capsules of 
Cinnanomum verum: 
The (HED) for C. verum was found to be 1gram, thus o.5 grams of 
the completely dried alcoholic powdered extract was packed in (zero – 
size) gelatin capsules using the manual capsule machine. 2 capsules are 
recommended to be taken by the diabetic patient per day, to correspond 
the HED. 
2-2-2-10-3-Preparation of Antidiabetic Capsules of Citrus 
aurantifolin: 
The (HED) for C. aurantifolin was found to be 2gram, thus o.5 
grams of the completely dried alcoholic powdered extract was packed in 
(zero – size) gelatin capsules using the manual capsule machine. 4 
capsules are recommended to be taken by the diabetic patient per day, to 
correspond the HED. 
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Chapter Three 
 
3-Results 
 
This research studied the hypoglycaemic activity, pharmacology 
and toxicology of the aqueous and alcoholic extracts of Cicer arientinum, 
Cinnamomum verum and Citrus aurantifolin in hyperglycaemic rats (type 
II) and in sterptozotocin-induced diabetic rats (type I). 
3-1-Yield of extracts 
The alcoholic extract of C.arientinum was watery and yellow, 
C.verum was sticky and brown and that of C. aurantifolin was sticky and 
green. 
All aqueous extracts were in powder-form (freeze- dried).The powder of 
C. arientinum revealed a yellow colour, C.verum a brown colour and C. 
aurantifolin a green colour.The yield percentage was calculated for the 
for  the three study plants. The aqueous extract of C.arientinum yield was 
o.7% and its alcoholic yield was 1.4%. The aqueous extract of C.verum 
yield was 1.0% while its methanolic extract yielded 2.6%. The aqueous 
extract of C.aurantifolin yield was 5.3% and its alcoholic extract yield 
was 10.7%., as demonstrated in table (3-1). 
3-2-Phytochemical Screening 
 General phytochemical screening was performed for C.arientinum, 
C.verum and C. aurantifolin to identify their chemical constituents.. 
Alkaloids and saponins were common constituents of the three study 
plants. Besides that C.arientinum revealed presence of sterols, cyanigenic 
glycosides and coumarins. C.verum revealed presence of triterpenes and 
tannins, while C.aurantifolin revealed presence of sterols, flavonoides, 
tannins, cyanogenic glycosides and coumarins (table 3-2). 
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(Table 3-1) Yield percentage of the study plants 
Study plant Extract Initial 
weight(g) 
Final 
weight(g) 
Yield 
(%) 
Cicer 
arientinum 
Aqueous 
Alcoholic
100 
100 
0.56 
1.44 
0.7 
1.4 
Cinnamomum 
verum
Aqueous 
Alcoholic
100 
100 
1.04 
2.55 
1.0 
2.6 
Citrus 
aurantifolin
Aqueous 
Alcoholic
50 
50 
2.65 
5.33 
5.3 
10.7 
 
 
(Table 3-2) Phytochemical Screening of the Study Plants 
Chemical 
Ingredient
Cicer 
arientinum
Cinnamomum 
verum 
Citrus 
aurantifolin
Sterols + - ++ 
Triterpenes - + - 
Alkaloids + + + 
Flavonoides - - + 
Tannins - + + 
Anthraquinones - - - 
Saponin ++ + + 
Cyanogenic 
glycosides
++ - + 
Coumarins ++ - + 
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3-3. Non Insulin Dependent Diabetes Mellitus 
(Type II) 
3-3-1.Cicer arientinum 
3-3-1-1.  Effects of  the aqueous  extract of C.arientinum on blood 
glucose , cholesterol and triglycerides of hyperglycaemic rats. 
In studying the effect of the aqueous extract of C.arientinum on 
blood glucose level of hyperglycaemic rats, the two doses (400 and 200 
mg/kg) showed significant hypoglycaemic effect (P<0.001) 1 and 2 hours 
after extract administration, as compared to the control. The effect 
continued but with a lesser significance (P<0.05).The glucose lowering 
effect of the reference drug Glibenclamide was not significant, as 
demonstrated in table (3-3) and figure (3-1). Regarding the extract effect 
on blood cholesterol, dose 400mg/kg started a highly significant 
reduction (P<0.001) at the first hour post dosing and (P<0.05) at the 
second hour, while dose 200mg/kg started a significant reduction 
(P<0.05) at the first and continued with an increased significant reduction 
(P<0.001), two hours post dosing; (table 3-4). The same effect was 
revealed on blood triglycerides two hours post dosing as compared to the 
control, (table 3-5). 
3-3-1-2. Effects of the methanolic extract of C.arientinum on blood 
glucose, cholesterol and triglycerides of hyperglycaemic rats. 
Compared to the control, dose 400mg/kg expressed a significant 
reduction (P<0.05) on blood glucose level since the 1st hour, the effect 
continued till the 4th hour. Dose 200mg/kg reduced blood glucose 
significantly (P<0.001), (P<0.001) and (P<0.05) 1, 2 and 4 hours 
respectively post dosing. The reference drug, Glibenclamide showed a 
significant reduction (P<0.05), at the 2nd hour, as illustrated in table (3-6). 
Regarding blood lipids, both doses lowered the level of blood cholesterol 
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and triglycerides, significantly (P<0.001) since the first hour of extract 
administration, (tables 3-7 and 3-8). 
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(Fig.3-1)  
 
 
 
 
 
 
 
 
 
 
 
 
 
(Table 3-3) Effect of the aqueous extract of C.arientinum on the blood glucose of 
hyperglycaemic  rats: 
Blood Glucose (mg/dl) 
Name Of Group
Time (hours)  
0 1 2 4 
Control (D.W.) 110± 8.9 
 
166.8±7.51 
 
129.4±17 
 
110.4±8.5 
 
Glibenclamide (10 mg/kg) 105±5.8 
 
141.7±32.8 
 
87.38±2.89*
 
86.7±10.45*
 
C. arientinum (400 
mg/kg) 
80.98±4.4 
 
106.2±13.6**
 
62.3±4.27**
 
88.8±2.45* 
 
C. arientinum (200 
mg/kg)
93.7±3.7 
 
88.4±1.25** 
 
90.2±2.3** 
 
80.7±1.25* 
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05), 
** = (P<0. 001) 
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(Table 3-4)  Effect of the aqueous extract of C.arientinum on the blood 
cholesterol of hyperglycaemic rats:  
Blood Cholesterol (mg/dl) 
Name Of Group
Time (hours) 
0 1 2 4 
Control (D.W.) 75.8±6.7 
 
104.2±16.8
 
107.2±6.4 
 
83.5±6.4 
 
Glibenclamide (10 mg/kg) 88±8.87 
 
87±8.2 
 
83.6±2.8 
 
86.4±21.2 
 
C. arientinum (400 mg/kg) 92±22.5 
 
80.2±3.5**
 
78.6±5.3* 
 
75.8±11.86
 
C. arientinum (200 mg/kg) 62.8±6 
 
73±6.2* 
 
72.6±6.4**
 
79±4.6 
 
(Data are expressed in mean± standard error of mean) 
* =   (P<0.05). 
** =   (P<0.001). 
 
(Table 3-5) Effect of the aqueous extract of C. arientinum on the blood 
triglycerides of hyperglycaemic rats: 
Blood Triglycerides (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (distilled water 10 
ml/kg)
108±13.6 
 
118.5±11.2
 
135.2±19.4
 
122.2±16.5
 
Glibenclamide (10 mg/kg) 132.2±10.5
 
140.6±10.2
 
134.8±16.3
 
144.4±9.4 
 
C. arientinum (400 mg/kg) 146.8±12.4
 
153.6±7.5 
 
129.6±5.9*
 
140.6±11.8
 
C. arientinum (200 mg/kg) 145.2±13.9
 
121.6±12.4
 
117.2±6.5*
 
150.2±10.6
 
(Data are expressed in mean ± standard error of mean) 
*   =   (P<0.05). 
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(Fig. 3-2)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Table 3-6)  Effect of the methanolic extract of C. arientinum on the blood 
glucose of hyperglycaemic rats: 
Blood Glucose (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (D.W.) 110±8.9 
 
166.8±7.51
 
129.4±17 
 
110.4±8.5 
 
Glibenclamide (10 mg/kg) 105±5.8 
 
141.7±32.8
 
87.38±2.89*
 
86.7±10.45
 
C. arientinum (400 mg/kg) 71±1.84 
 
131±5* 
 
87.5±1.74* 
 
72.8±1.65*
 
C. arientinum (200 mg/kg) 66.6±2.37
 
136±7.2** 74.8±1.46**
 
81±17.2* 
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05), 
* *  =   (P<0.001), 
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(Table 3-7)  Effect of the methanolic extract of C. arientinum on the blood 
cholesterol of hyperglycaemic rats: 
Blood Cholesterol (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (D.W.) 75.8±6.7 
 
104.2±16.8
 
107.2±6.4 
 
83.5±6.4 
 
Glibenclamide (10 mg/kg) 88±8.87 87±8.2 
 
83.6±2.8 
 
86.4±21.2 
 
C. arientinum (400 mg/kg) 55.2±1.6*
 
66±4.7** 
 
56.8±1.3**
 
51.2±2.7**
 
C. arientinum (200 mg/kg) 71.4±3.1 
 
74.6±8.3**
 
65.4±1.9**
 
55.6±6.1**
 
(Data are expressed in mean± standard error of mean) 
** = (P<0. 001). 
 
(Table 3-8)  Effect of the methanolic extract of C. arientinum on the blood 
triglycerides of hyperglycaemic rats: 
Blood Triglycerides (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (D.W.) 108±13.6 
 
118.5±11.2
 
135.2±19.4
 
122.2±16.5 
 
Glibenclamide (10 mg/kg) 132.2±10.5
 
140.6±10.2
 
134.8±16.3
 
144.4±9.4 
 
C. arientinum (400 mg/kg) 125±8.6 
 
72±4.1** 
 
54.2±1.7**
 
65.8±1.5** 
 
C. arientinum (200 mg/kg) 122.4±3.2 
 
60±1.8** 
 
56.6±4.2**
 
66.2±10.5**
 
 
(Data are expressed in mean± standard error of mean) 
** = (P<0. 001). 
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3-3-2 Cinnamomum verum  
3-3-2-1. Effects of  the aqueous  extract of C.verum on blood glucose 
cholesterol and triglycerides of hyperglycaemic rats.  
In studying the effect of the aqueous extract of C.verum on blood 
glucose level of hyperglycaemic rats, the two doses (400 and 200 mg/kg) 
showed a significant hypoglycaemic effect (P<0. 001) since the first hour 
of dose administration as shown in table (3-9). The hypoglycaemic effect 
of the reference drug Glibenclamide was not significant as compared to 
the control. Regarding its effect on blood lipids, neither blood cholesterol 
nor blood triglycerides were significantly reduced by the extract, (tables 
3-10 & (3-11). 
3-3-2-2. Effects of  the methanolic extract of C.verum on blood 
glucose cholesterol and triglycerides of hyperglycaemic rats.  
Compared to the control, dose (400 mg/kg) showed a significant 
reduction (P<0. 001) in the level of blood sugar, one hour after 
administration of the extract, this effect continued but with a lesser 
significance (P<0.05).  Table (3-12) and Fig (3-4). illustrate the 
hypoglycaemic effect of dose (200 mg/kg) which was highly significant 
(P<0. 001). Regarding the effect on blood cholesterol, there was no 
significant reduction, as compared to the control (table 3-13). With 
respect to blood triglycerides, the two doses of the methanolic extract of 
C.verum produced a significant reduction (P<0.05) 2 and 4 hours post 
dosing, (table 3-14). 
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(Fig. 3-3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Table 3-9) Effect of the aqueous extract of C.verum on the blood glucose of 
hyperglycaemic  rats: 
Blood Glucose (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (D.W.) 110±8.9 
 
166.8±7.51
 
129.4±17 
 
110.4±8.5 
 
Glibenclamide (10 mg/kg) 105±5.8 
 
141.7±32.8
 
87.38±2.89*
 
86.7±10.45
 
C. verum (400 mg/kg) 73.9±9.9
 
93.5±1.9**
 
92.7±2** 
 
87.5±9.7**
 
C. verum (200 mg/kg) 93.6±7.5
 
88.8±7.9**
 
85±2.3** 
 
72.5±4.1**
 
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05), 
** = (P<0. 001) 
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(Table 3-10)  Effect of the aqueous extract of C. verum on the blood cholesterol of 
hyperglycaemic rats: 
Blood Cholesterol (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (D.W.) 75.8±6.7 
 
104.2±16.8 
 
107.2±6.4 
 
83.5±6.4 
 
Glibenclamide (10 mg/kg) 88±8.87 
 
87±8.2 
 
83.6±2.8 
 
86.4±21.2 
 
Cverum (400 mg/kg) 69.4±5.1 
 
111.8±20.5 92.6±17.9 86.7±1.4 
 
Cverum (200 mg/kg) 70.2±3.7 
 
72.8±4.6 
 
90.4±1.8 
 
80.6±6.9 
 
 
(Data are expressed in mean± standard error of mean) 
 
(Table 3-11)  Effect of the aqueous extract of C. verum on the blood triglycerides of 
hyperglycaemic rats: 
Blood triglycerides (mg/dl) 
 Name 
Of Group  
Time (hours) 
0 1 2 4 
Control (D.W.) 108±13.6 
 
118.5±11.2
 
135.2±19.4
 
122.2±16.5
 
Glibenclamide (10 mg/kg) 132.2±10.5 
 
140.6±10.2
 
134.8±16.3
 
144.4±9.4 
 
C. arientinum (400 mg/kg) 138.4±11 
 
144±4.5 
 
121±14.2 
 
115±10. 
 
C. arientinum (200 mg/kg) 131.2±10.9 
 
129.2±6 
 
136.8±8.5 
 
120.2±7.5 
 
 
(Data are expressed in mean± standard error of mean) 
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(Fig. 3-4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Table 3-12)  Effect of the methanolic extract of C. verum on the blood glucose of 
hyperglycaemic rats 
 
Blood Glucose (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (D.W.) 110±8.9 
 
166.8±7.51 
 
129.4±17 
 
110.4±8.5 
 
Glibenclamide (10 mg/kg) 105±5.8 
 
141.7±32.8 
 
87.38±2.89
 
86.7±10.45
 
C. verum (400 mg/kg) 108.6±8.3
 
122.5±1.2**
 
90.6±16.2*
 
90.7±11.2*
C. verum (200 mg/kg) 97.6±7.6 
 
104.2±15** 
 
91.2±7.4**
 
78±5.5** 
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05), 
** = (P<0. 001) 
 
 71
(Table 3-13)  Effect of the methanolic extract of C. verum on the blood 
cholesterol of hyperglycaemic rats: 
Blood Cholesterol (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (D.W.) 75.8±6.7 
 
104.2±16.8 
 
107.2±6.4 
 
83.5±6.4 
 
Glibenclamide (10 mg/kg) 88±8.87 
 
87±8.2 
 
83.6±2.8 
 
86.4±21.2 
 
C. arientinum (400 mg/kg) 69.4±5.1 
 
92.6±17.9 
 
101.8±20.5 
 
86.7±1.4 
 
C. arientinum (200 mg/kg) 70.2±3.7 
 
72.8±4.6 
 
90.4±1.8 
 
80.6±6.9 
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05), 
** = (P<0. 001) 
 
(Table 3-14)  Effect of the methanolic extract of C. verum on the blood triglycerides 
of hyperglycaemic rats: 
Blood triglycerides (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (D.W.) 108±13.6 
 
118.5±11.2 
 
135.2±19.4 
 
122.2±16.5 
 
Glibenclamide (10 mg/kg) 132.2±10.5 
 
140.6±10.2 
 
134.8±16.3 
 
144.4±9.4 
 
C. arientinum (400 
mg/kg)
138.4±11 
 
124±4.5 
 
111±14.2* 
 
105±10.* 
 
C. arientinum (200 
mg/kg)
131.2±10.9 
 
129.2±6 
 
116.8±8.5* 
 
108.2±7.5* 
 
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05),  
** = (P<0. 001) 
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3-3-3. Citrus aurantifolin  
3-3-3-1. Effects of the aqueous extract of C.aurantifolinon blood 
glucose cholesterol and triglycerides of hyperglycaemic rats.  
In studying the effect of the aqueous extract of C.aurantifolin, on 
blood glucose level of hyperglycaemic rats, both doses,  reduced blood 
glucose significantly (P<0.05), (P<0. 001) and (P<0. 001) 1, 2 and 4 
hours post dosing respectively. Table (3-15), illustrates that the reference 
drug Glibenclamide showed no significant reduction as compared to the 
control. Table (3-16), reveals that, both doses of the aqueous extract of C. 
aurantifolin, reduced blood cholesterol significantly (P<0.001) 1 hour 
post dosing. The effect of dose (200 mg/kg) was more persistent. 
Regarding blood triglycerides, dose (400 mg/kg) revealed a significant 
reduction (P<0. 001) 2 and 4 hours post dose administration, as 
demonstrated in table (3-17). 
3-3-3-2. Effects of the methanolic extract of C.aurantifolinon blood 
glucose cholesterol and triglycerides of hyperglycaemic rats.  
Dose (400 mg/kg) revealed a significant reduction in blood glucose 
(P<0. 001) and (P<0.05), one and two hours post dosing, respectively. 
Dose (200 mg/kg) showed a significant reduction (P<0.05), one hour 
after administration of extract. The reference drug Glibenclamide 
revealed a significant reduction (P<0.05).two hours post dosing, as 
illustrated in table (3-18). Regarding the effect on blood lipids, the two 
doses showed a reduction on the level of blood cholesterol. The reference 
drug Glibenclamide revealed a significant reduction (P<0.05), two hours 
post dosing as illustrated in table (3-19). The two doses of the methanolic 
extract of C.aurantifolin, as demonstrated in table (3-20), showed a non 
significant reduction on the level of blood triglycerides of 
hyperglycaemic rats.  
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(Fig.3-5)  
 
 
 
 
 
 
 
 
 
 
 
 
 
(Table 3-15) Effect of the aqueous extract of C.aurantifolin on the blood glucose of 
hyperglycaemic rats: 
Blood Glucose (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (D.W.) 110±8.9 
 
166.8±7.51
 
129.4±17 
 
110.4±8.5 
 
Glibenclamide (10 mg/kg) 105±5.8 
 
141.7±32.8
 
87.38±2.89*
 
86.7±10.45 
 
C. aurantifolin (400 mg/kg) 90±10.6 
 
149.5±9.1*
 
76±10.5** 
 
75.9±6.9** 
 
C. aurantifolin (200 mg/kg) 87.8±2.7
 
127±11.3*.
 
87.2±4.8** 
 
100.9±0.73*
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05), 
** = (P<0. 001) 
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(Table 3-16)  Effect of the aqueous extract of C.aurantifolin on the blood cholesterol 
of hyperglycaemic rats: 
Blood Cholesterol (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (D.W.) 75.8±6.7
 
104.2±16.8
 
107.2±6.4 
 
83.5±6.4 
 
Glibenclamide (10 mg/kg) 88±8.87 
 
87±8.2 
 
83.6±2.8* 
 
86.4±21.2 
 
C. arientinum (400 mg/kg) 66.6±4.8
 
67.8±9.6**
 
107.2±13.2
 
83.5±6.4 
 
C. arientinum (200 mg/kg) 57.4±4.5
 
71.8±5.6**
 
68.6±4.4**
 
67.7±6.8**
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05), 
** = (P<0. 001) 
 
(Table 3-17) Effect of the aqueous extract of C.aurantifolin on the blood triglycerides 
of hyperglycaemic rats: 
Blood triglycerides (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (water 10 ml/kg) 108±13.6 
 
118.5±11.2
 
135.2±19.4
 
122.2±16.5
 
Glibenclamide (10 mg/kg) 132.2±10.5
 
140.6±10.2
 
134.8±16.3
 
144.4±9.4 
 
C. arientinum (400 mg/kg) 115.4±16.7
 
135.2±19.4
 
87±22.4** 
 
74±20** 
 
C. arientinum (200 mg/kg) 131±10.5 
 
115.2±9.7 
 
118.4±5.3*
 
108.5±14.9
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05) 
** = (P<0. 001). 
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(Fig.3-6)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 (Table 3-18)  Effect of the methanolic extract of C. aurantifolin on the blood glucose 
of hyperglycaemic rats: 
Blood Glucose (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (D.W.) 110± 8.9 
 
166.8±7.51
 
129.4±17 
 
110.4±8.5 
 
Glibenclamide (10 mg/kg) 105±5.8 
 
141.7±32.8
 
87.38±2.89
 
86.7±10.45
 
C. aurantifolin (400 mg/kg) 100.2±2.4 
 
82.2**±15 
 
76.4±3.6* 
 
88.5±8.8 
 
C. aurantifolin (200 mg/kg) 105±8.7 
 
138.2±2.1*
 
119.1±6.7 
 
91.9±1.6 
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05), 
** = (P<0. 001). 
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(Table 3-19)  Effect of the methanolic extract of C. aurantifolin on the blood 
cholesterol of hyperglycaemic rats: 
Blood Cholesterol (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (D.W.) 75.8±6.7
 
104.2±16.8
 
107.2±6.4
 
83.5±6.4 
 
Glibenclamide (10 mg/kg) 88±8.87 
 
87±8.2 
 
83.6±2.8 
 
86.4±21.2
 
C. arientinum (400 mg/kg) 72.6±5.1
 
104.2±16.8
 
93.2±21.6
 
75.8±4.6 
 
C. arientinum (200 mg/kg) 65±3.7 
 
79.8±21.6*
 
88.2±6.4*
 
80±6 
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05), 
** = (P<0. 001). 
 
 
 (Table 3-20)  Effect of the methanolic extract of C. aurantifolin on the blood 
triglycerides of hyperglycaemic rats: 
Blood triglycerides (mg/dl) 
 Name Of Group
 
Time (hours) 
0 1 2 4 
Control (D.W.) 108±13.6 
 
118.5±11.2
 
135.2±19.4
 
122.2±16.5
 
Glibenclamide (10 mg/kg) 132.2±10.5
 
140.6±10.2
 
134.8±16.3
 
144.4±9.4 
 
C. arientinum (400 mg/kg) 123.8±9.7 
 
131.2±5.6 
 
120.8±9.5 
 
114.4±7.5 
 
C. arientinum (200 mg/kg) 125.4±19.2
 
114±22.4 
 
101.4±11.8
 
99.4±16.3 
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05), 
** = (P<0. 001). 
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3-4. Insulin-Dependent Diabetes Mellitus 
 
(Type I) 
 
3-4-1. Cicer arientinum 
 
3-4-1-1. Effects of the aqueous extract of C.arientinumon blood 
glucose cholesterol and triglycerides of diabetic ats.  
Compared to the control dose 400 mg/kg of the aqueous extract of 
C.arientinum, revealed a significant hypoglycaemic effect (P<0.05) 
throughout the experiment. The effect was more significant (P<0. 001) at 
the 12th hour post extract administration. The smaller dose (200 mg/kg) 
revealed a slower but highly significant effect (P<0.001).The reference 
drugs Glibenclamide and Insulin, revealed no significant hypoglycaemic 
effects as shown in table (3-21). Regarding blood cholesterol, the two 
doses (400 and 200 mg/kg) of the aqueous extract of C.arientinum 
exerted no significant effect. Table (3-22), demonstrates that, Insulin 
exerted a significant reduction (P<0.05), four and eight hours 
respectively, after dosing. Regarding blood triglycerides, dose (400 
mg/kg) showed a  significantl reduction (P<0.001), twelve hours after 
administration of the extract. Dose 200mg/kg showed a more persistent 
and significant lowering effect (P<0.05), (P<0.05) and (P<0.001) 
respectively 4, 8 and 12 hours after extract administration. Insulin 
produced a significant reduction (P<0.001), four and eight hours 
respectively, after dosing, as demonstrated in table (3-23). 
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3-4-1-2. Effects of the methanolic extract of C.arientinumon blood 
glucose cholesterol and triglycerides of diabetic ats.  
 As illustrated in table (3-24), both doses of the methanolic extract 
of C.arientinum, produced a significant hypoglycaemic activity 
(P<0.001), twelve hours after administration of the extract, as compared 
to the contro. The reference Glibenclamide revealed no significant effect, 
while Insulin exerted a significant reduction (P<0.05), at the 12th hour, 
post dosing. Regarding its effect on blood lipids, none of the doses 
reduced blood cholesterol significantly table (3-25). Table (3-26), reveals 
that,  dose (400 mg/kg) exerted a significant lowering effect (P<0. 001) 
on the level of blood triglycerides of diabetic rats after twelve hours from 
extract administration.  Similar to Glibenclamide, dose 200 mg/kg 
showed no lowering effect on blood triglycerides, while Insulin reduced 
blood triglycerides significantly (P<0.001) 4, 8, and 12 hours post 
administration.  
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(Fig.3-7)  
 
 
 
 
 
 
 
 
 
 
 
 
(Table 3-21)  Effect of the aqueous extract of C.arientinum on the blood glucose of 
diabetic rats: 
Blood Glucose (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 286.2±18.2
 
226.6±12.5 
 
202.8±56.5 
 
277±56.5 
 
Glibenclamide (10 mg/kg) 311.8±46.3
 
221.2±55 
 
259.8±64.9 
 
266.6±49.4 
 
 Soluble Insulin (3U/kg) 273.6±18.3
 
286.8±6.6 
 
226±2.8 
 
222±6.6 
 
C. arientinum (400 mg/kg) 255.6±14.8
 
199.2±16.4*
 
190.6±26.5*
 
162±27.6** 
 
C. arientinum(200 mg/kg) 211±16.6 
 
249.2±23.8 
 
208.8±25.3 
 
205.4±15.1**
 
(Data are expressed in mean± standard error of mean) 
* = (P<0. 05) 
** = (P<0. 001) 
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(Table 3-22)  Effect of the aqueous extract of C.arientinum on the blood cholesterol 
of diabetic rats: 
Blood Cholesterol (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 66±10.2 61±3.7 53±5.4 56.8±5.9 
Glibenclamide (10 mg/kg) 98.6±18.6 112±17.4 97.4±15 56.8±4.9 
Soluble Insulin (3U/kg) 40.4±2.5 31.4±3* 34.2±.8* 
 
42±2.1 
C. arientinum (400 mg/kg) 75.6±12.3 71±14.5 70±15.5 54.8±5.2 
C. arientinum (200 mg/kg) 77.4±5.1 65±17.7 94.4±20.8 57.8±11.2
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05) 
 
(Table 3-23)  Effect of the aqueous extract of C.arientinum   on the plasma 
triglycerides level of diabetic rats: 
Blood Triglycerides (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 247.2±35.7 
 
227.8±20.3 
 
187±15.3 
 
284±54.3 
 
Glibenclamide (10 mg/kg) 123.2±22.5 
 
222.4±52.3 
 
247±55.9 
 
230.4±61.5 
 
Soluble Insulin (3 U/kg) 57.8±12.8 
 
33.2±4.8** 
 
33.6±2.5** 
 
242±6.5 
 
C. arientinum (400 mg/kg) 225.6±18.7 
 
239.8±125.3
 
206.2±104.7
 
106±58.5**
 
C. arientinum (200 mg/kg) 190.4±78.8 
 
176.8±40.3*
 
168.4±107* 
 
75±12.6** 
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05), 
** = (P<0. 001) 
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(Fig.3-8) 
Effect of the methanolic extract of 
C.arientinum on the glucose level of diabetic 
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(Table 3-24)  Effect of the methanolic extract of C.arientinum on the blood glucose 
of diabetic rats: 
Blood Glucose (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 286.2±18.2
 
226.6±12.5
 
202.8±56.5
 
277±56.5 
 
Glibenclamide (10 mg/kg) 311.8±46.3
 
221.2±55 
 
259.8±64.9
 
266.6±49.4 
 
Soluble Insulin (3U/kg) 273.6±18.3
 
286.8±6.6 
 
226±2 
 
222±6.6 
 
C. aurantifolin (400 mg/kg) 258±12.9 
 
300.4±10.7
 
274.2±30.9
 
181±3.7** 
 
C. aurantifolin (200 mg/kg) 274.8±13.4
 
264.8±38.6
 
300.4±16.3
 
161.6±32.4**
 
(Data are expressed in mean± standard error of mean) 
** = (P<0. 001) 
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(Table 3-25)  Effect of the methanolic extract of C.arientinum on the blood 
cholesterol of diabetic rats: 
Blood Cholesterol (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 66±10.2 61±3.7 53±5.4 56.8±5.9 
Glibenclamide (10 mg/kg) 98.6±18.6 112±17.4 97.4±15 56.8±4.9 
Soluble Insulin (3U/kg) 40.4±2.5 31.4±3 34.2±.8 42±2.1 
C. arientinum (400 mg/kg) 67±8.8 71.8±21 63.4±16 40.8±4.4 
C. arientinum (200 mg/kg) 78.6±15.6 57±12 76.4±15.2 66.3±10.2
(Data are expressed in mean± standard error of mean) 
 
 (Table 3-26)  Effect of the methanolic extract of C.arientinum on the blood 
triglycerides of diabetic rats: 
Blood triglycerides (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 247.2±35.7 
 
227.8±20.3
 
187±15.3 
 
284±54.3 
 
Glibenclamide (10 
mg/kg)
123.2±22.5 
 
222.4±52.3
 
247±55.9 
 
230.4±61.5 
 
Soluble Insulin (3U/kg) 57.8±12.8 
 
33.2±4.8**
 
33.6±2.5**
 
42±6.5** 
 
C. arientinum (400 
mg/kg) 
213.6±20.9 
 
280±102.6 
 
276.6±89 
 
159.8±51.1**
 
C. arientinum (200 
mg/kg)
267.8±36.7 
 
297.4±29.2
 
285.4±36 
 
238.8±24.9 
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05),  
** = (P<0. 001) 
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3-4-2 Cinnanomum verum  
3-4-1-1. Effects of the aqueous extract of C.verum on blood glucose 
cholesterol and triglycerides of diabetic ats.  
Table (3-27), reveals that, dose (400 mg/kg) reduced blood glucose 
level of diabetic rats significantly (P<0.05), (P<0.001), 8 and 12 hours 
post dosing respectively, as compared to the control.. Dose (200 mg/kg) 
exerted a significant hypoglycaemic effect (P<0. 001) after 12 hours. 
Neither Glibenclamide nor insulin reduced blood glucose level of diabetic 
rats. The results are illustrated on (table 3-28), show that, neither C. 
verum, nor Insulin, produced a significant reduction on the blood level of 
diabetic rats diabetic rats. Regarding blood triglycerides, both doses of 
the aqueous extract of C.verum produced a significant lowering effect 
(P<0. 001) 8 and 12 hours post dosing. Table (3-29), shows that, the 
lowering effect exerted by insulin has an early onset as it started since the 
4 th hour post dosing.  
3-4-1-2. Effects of the methanolic extract of C.verum on blood glucose 
cholesterol and triglycerides of diabetic ats.  
Both doses of the methanolic extract of C.verum produced a slow but 
highly significant reduction on the glucose blood level of diabetic rats at 
the 12 th hour post extract administration. Neither Glibenclamide nor 
insulin revealed a significant hypoglycaemic effect on diabetic rats as 
shown on (table 3-30). 
Regarding blood cholesterol, C.verum, showed no significant reduction 
on the blood cholesterol level of diabetic rats, while Insulin produced a 
significant reduction (P<0. 05), four hours after dosing, as demonstrated 
in   (table 3-31). Both doses of the methanolic extract of C.verum as well 
as the reference drug (insulin) showed a significant lowering effect (P<0. 
001) on the level of blood triglycerides. The onset of the effect of insulin 
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was earlier as it started since the 4th hour post dosing while the effect of 
the extract appeared at the 12th hour, table (3-32). 
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(Fig 3-9)  
 
 
 
 
 
 
 
 
 
 
 
 
(Table 3-27) Effect of the aqueous extract of C. verum on the blood glucose of 
diabetic rats: 
Blood Glucose (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 286.2±18.2
 
226.6±12.5
 
202.8±56.5 
 
277±56.5 
 
Glibenclamide (10 mg/kg) 311.8±46.3
 
221.2±55 
 
259.8±64.9 
 
266.6±49.4 
 
Soluble Insulin (3U/kg) 273.6±18.3
 
286.8±6.6 
 
226±2 
 
222±6.6 
 
C.verum (400 mg/kg) 303±7.2 
 
254.4±23.4
 
182.4±62.8*
 
156.2±42.2**
 
C.verum (200 mg/kg) 293.8±7.7 
 
269.2±45.1
 
202.8±31.5 
 
186±18.7** 
 
Data are expressed in mean ± standard error of mean 
* = (P<0.05)  
** = (P<0. 001) 
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(Table 3-28) Effect of the aqueous extract of C. verum on the blood cholesterol of 
diabetic rats: 
Blood Cholesterol (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W) 66±10.2 61±3.7 53±5.4 56.8±5.9 
Glibenclamide (10 mg/kg) 98.6±18.6 112±17.4 97.4±15 56.8±4.9 
Soluble Insulin (3U/kg) 40.4±2.5 31.4±3 34.2±.8 42 ±2.1 
C.verum   (400 mg/kg) 95.8±6.5 79±20.6 50.6±6.7 50±1.6 
C.verum   (200 mg/kg) 100.4±53 73.2±13.8 58.6±19.3 54.4±19.2
(Data are expressed in mean ± standard error of mean) 
*   =   (P<0.05). 
 
 (Table 3-29) Effect of the aqueous extract of C. verum on the blood triglycerides of 
diabetic rats: 
Blood triglycerides (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 247.2±35.7
 
227.8±20.3
 
187±15.3 
 
284±54.3 
 
Glibenclamide (10 mg/kg) 123.2±22.5
 
222.4±52.3
 
247±55.9 
 
230.4±61.5 
 
Soluble Insulin (3U/kg) 57.8±12.8 
 
33.2±4.8**
 
33.6±2.5** 
 
42±6.5** 
 
C.verum (400 mg/kg) 285.8±34.8
 
305±47.1 
 
88.6±19.2**
 
165±64.7**
 
C.verum (200 mg/kg) 186.8±65.7
 
227.8±20.3
 
88.2±29.5**
 
88.6±28** 
 
(Data are expressed in mean± standard error of mean)  
** = (P<0. 001). 
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(Fig. 3-10) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Table 3-30) Effect of the methanolic extract of C. verum on the blood glucose of 
diabetic rats: 
Blood Glucose (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 286.2±18.2
 
226.6±12.5
 
202.8±56.5
 
277±56.5 
 
Glibenclamide (10 mg/kg) 311.8±46.3
 
221.2±55 
 
259.8±64.9
 
266.6±49.4 
 
Soluble Insulin (3U/kg) 273.6±18.3
 
286.8±6.6 
 
226±2 
 
222±6.6 
 
C.verum (400 mg/kg) 235.4±12.4
 
315.6±31.9
 
206.2±54.1
 
203.6±57.1**
 
C.verum (200 mg/kg) 239.4±15.4
 
220.4±25.9
 
205.6±32.3
 
187.4±41.7**
 
(Data are expressed in mean± standard error of mean)  
*   =   (P<0.05), 
** = (P<0. 001). 
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(Table 3-31)  Effect of the methanolic extract of C. verum on the blood cholesterol of 
diabetic rats: 
Blood Cholesterol (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 66±10.2 61±3.7 53±5.4 56.8±5.9
Glibenclamide (10 mg/kg) 98.6±18.6 112±17.4 97.4±15 56.8±4.9
Soluble Insulin (3U/kg) 40.4±2.5 31.4±3 34.2±.8 42±2.1 
C.verum   (400 mg/kg) 58.4±8.2 51.8±7.1 45.2±5.9 42.6±1.7
C.verum   (200 mg/kg) 79±3.4 48.6±5.1 52.8±2.5 47.8±2.9
(Data are expressed in mean± standard error of mean) 
 
 (Table 3-32) Effect of the methanolic extract of C. verum on the blood triglycerides 
of diabetic rats: 
Blood triglycerides (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 247.2±35.7
 
227.8±20.3
 
187±15.3 
 
284±54.3 
 
Glibenclamide (10 mg/kg) 123.2±22.5
 
222.4±52.3
 
247±55.9 
 
230.4±61.5 
 
Soluble Insulin (3U/kg) 57.8±12.8 
 
33.2±4.8**
 
33.6±2.5**
 
42±6.5** 
 
C.verum   (400 mg/kg) 210.8±51.2
 
283.4±16.2
 
165.2±22.6
 
165.8±43.7**
 
C.verum   (200 mg/kg) 179.8±65 
 
195±57.9 
 
223.2±61.4
 
165.2±43.1**
 
(Data are expressed in mean± standard error of mean)  
** = (P<0.01) 
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3-4-3- Citrus aurantifolin 
3-4-3-1- Effects of the aqueous extract of C.aurantifolin on blood 
glucose cholesterol and triglycerides of diabetic ats. 
Compared to the control, both doses (400 and 200 mg/kg) of the 
aqueous extract of C.aurantifolin reduced the level of blood glucose of 
diabetic rats significantly (P<0.05), (P<0.001), 4 and 8 hours after extract 
administration respectively. The hypoglycaemic effect exerted by the 
extract was greater than that produced by the reference drugs 
Glibenclamide and Insulin, as illustrated in (table 3-33). Regarding blood 
cholesterol, table (3-34). Illustrates that, both doses of the aqueous extract 
of C.aurantifolin, showed a non significant reduction in diabetic rats, 
while Insulin exerted a significant reduction (P<0. 05) at the 4th hour post 
dosing. Regarding blood triglycerides, table (3-35), shows that, the two 
doses, similar to Insulin, reduced the level of blood triglycerides 
significantly (P<0. 001) throughout the 12 hours of the experiment, while 
Glibenclamide exerted a slight and slow significant reduction (P<0. 05) at 
the 12th hour post dosing. 
3-4-3-2- Effects of the methanolic extract of C.aurantifolin on blood 
glucose cholesterol and triglycerides of diabetic ats. 
  Table (3-36), demonstrates that, both doses exerted a significant 
hypoglycaemic effect (P<0.001), in diabetic rats 12 hours after extract 
administration. Neither Glibenclamide nor insulin reduced blood glucose. 
Regarding blood cholesterol, C.aurantifolin, showed no significant 
reduction diabetic rats, while Insulin revealed a significant reduction 
(P<0. 05) at the 4th hour post dosing, as shown in table (3-37). Regarding 
blood triglycerides, both doses, reduced the level of blood triglycerides of 
diabetic rats significantly (P<0.05), (P<0. 001) 8 and 12 hours post 
extract administration. The reference drug insulin produced a highly 
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significant reduction (P<0. 001), since the 4th hour and the effect persisted 
till the 12th hour. Glibenclamide showed no effect, (table 3-38). 
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(Fig.3-11)  
 
 
 
 
 
 
 
 
 
 
 
 
 
(Table 3-33) Effect of the aqueous extract of C. aurantifolin on the blood glucose of 
diabetic rats: 
Blood Glucose (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 286.2±18.2 
 
226.6±12.5
 
202.8±56.5 
 
277±56.5 
 
Glibenclamide (10 mg/kg) 311.8±46.3 
 
221.2±55 
 
259.8±64.9 
 
266.6±49.4 
 
Soluble Insulin (3U/kg) 273.6±18.3 
 
286.8±6.6 
 
226±2 
 
222±6.6 
 
C. aurantifolin (400 
mg/kg) 
210.4±19.5**
 
249.6±20.2
 
184.8±2.2* 
 
130.8±2.2**
 
C. aurantifolin (200 
mg/kg)
314±44
 
247.2±52.3
 
180.6±14.4*
 
160.6±5** 
 
Data are expressed in mean± standard error of mean  
*   =   (P<0.05), 
** = (P<0. 001). 
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(Table 3-34) Effect of the aqueous extract of C. aurantifolin on the cholesterol of 
diabetic rats: 
Blood Cholesterol (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 66±10.2 61±3.7 53±5.4 56.8±5.9
Glibenclamide (10 mg/kg) 98.6±18.6 112±17.4 97.4±15 56.8±4.9
Soluble Insulin (3U/kg) 40.4±2.5 31.4±3* 34.2±.8 42±2.1 
C.aurantifolin  (400 mg/kg) 75.8±12.7 51±4.7 39.6±3.3 42.8±1.1
C.aurantifolin   (200 mg/kg) 65.6±13.7 87.4±13 48.8±.8 47.2±.7 
 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05), 
 
(Table 3-35) Effect of the aqueous extract of C. aurantifolin on the blood 
triglycerides of induced- diabetic rats: 
Blood triglycerides (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 247.2±35.7
 
227.8±20.3 
 
187±15.3 
 
284±54.3 
 
Glibenclamide (10 mg/kg) 123.2±22.5
 
222.4±52.3 
 
247±55.9 
 
230.4±61.5*
 
Soluble Insulin (U/kg) 57.8±12.8 
 
33.2±4.8** 
 
33.6±2.5**
 
42±6.5** 
 
C.aurantifolin (400 mg/kg) 122.2±14.3
 
55.8±12.8**
 
43.4±8** 
 
27.4±0.8** 
 
C.aurantifolin (200 mg/kg) 143.2±36.6
 
243±37** 
 
32.4±6.6**
 
44.4±5.3** 
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05), 
** = (P<0. 001). 
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(Fig. 3-12) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Table 3-36) Effect of the methanolic extract of C. aurantifolin on the blood glucose 
of induced- diabetic rats: 
Blood Glucose (mg/dl) 
 Name Of Group
 
Time (hours) 
0 4 8 12 
Control (D.W.) 286.2±18.2
 
226.6±12.5
 
202.8±56.5
 
277±56.5 
 
Glibenclamide (10 mg/kg) 311.8±46.3
 
221.2±55 
 
259.8±64.9
 
266.6±49.4 
 
Soluble Insulin (3U/kg) 273.6±18.3
 
286.8±6.6 
 
226±2 
 
222±6.6 
 
C. aurantifolin (400 mg/kg) 277.8±22.7
 
233.2±14.7
 
179.8±16.6
 
168.4±8.6** 
 
C. aurantifolin (200 mg/kg) 224.8±10 
 
223.6±6.8 
 
201±41.6 
 
171.4±29.8**
(Data are expressed in mean± standard error of mean) 
*   =   (P<0.05), 
** = (P<0. 001). 
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(Table 3-37) Effect of the methanolic extract of C. aurantifolin on the blood 
Cholesterol of induced- diabetic rats: 
Blood Cholesterol (mg/dl) 
 Name Of Group
 
Time (hours)  
0 4 8 12 
Control (D.W.) 66±10.2 61±3.7 53±5.4 56.8±5.9
Glibenclamide (10 mg/kg) 98.6±18.6 112±17.4 97.4±15 56.8±4.9
Soluble Insulin (3U/kg) 40.4±2.5 31.4±3* 34.2±.8 42±2.1 
C.aurantifolin   (400 mg/kg) 58.8±5.9 33±2.7 49.2±5.9 41±5.1 
C.aurantifolin   (200 mg/kg) 63.4±11 48±5.4 69±5.4 51.2±5 
(Data are expressed in mean± standard error of mean) 
** = (P<0. 05). 
 
 (Table3-38) Effect of the methanolic extract of C. aurantifolin on the blood 
triglycerides of induced- diabetic rats  
Blood triglycerides (mg/dl) 
 Name Of Group
 
Time (hours)  
0 4 8 12 
Control (D.W.) 247.2±35.7
 
227.8±20.3
 
187±15.3 
 
284±54.3 
 
Glibenclamide (10 mg/kg) 123.2±22.5
 
222.4±52.3
 
247±55.9 
 
230.4±61.5 
 
Soluble Insulin (U/kg) 57.8±12.8 
 
33.2±4.8**
 
33.6±2.5** 
 
42±6.5** 
 
C.aurantifolin   (400 
mg/kg)
210.2±51.2
 
283.4±16.2
 
165.2±43.7*
 
156.8±43.7**
 
C.aurantifolin   (200 
mg/kg)
179.8±65 
 
195±57.9 
 
165.2±61.4*
 
163.2±43.1**
 
(Data are expressed in mean± standard error of mean) 
** = (P<0. 05). 
* = (P<0. 001). 
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3-5 Pharmacology 
      The three plant extracts showed significant relaxant activity 
when tested on isolated rabbit jejunum in different doses (0.04 µg/ml, 
0.08 µg/ml and 0.16 µg /ml).  This relaxant activity in the plant extracts 
of C.arientinum and C.verum were blocked by different doses of 
Phentolamine. On the other hand the relaxant activity of the plant extract 
of C.aurantifolin was not blocked by any of blockers as demonstrated on 
table (3-39). 
 
 
(Table 3-39): Pharmacological screening of the study plant extracts: 
Plant name Concentration 
used (mg/ml)
Sub 
maximum 
dose (ml)
Response Blocker
C.arientinum 1 0.8 Relaxation Phentolamine
C.verum 20 0.8 Relaxation Phentolamine
C.aurantifn 1 0.8 Relaxation -
 
3-6. Toxicology 
3-6-1. Sub-chronic toxicity:   
The effect of methanolic extracts of C.arientinum, C.verum and C. 
aurantifolin on adult healthy rats receiving these plants for 21 days, 
revealed no significant alterations in blood haemogram, liver functions 
and kidney functions. The results of the liver functions represented by 
GOT, GPT and ALP showed no significant alteration as demonstrated in 
table (3-40).  Kidney function tests represented by creatinine, urea, Na 
and K showed no significant changes, compared to the control as 
demonstrated in table (3-41).  Similarly, the effect of these plants on 
blood haemogram represented by TWBCs, TRBCs and Hb are shown in 
table (3-42). 
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Furthermore, compared to the control, the histopathological investigation 
of these plants revealed normal hepatocytes as demonstrated in table (3-
43). 
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(Table 3-40) Liver function 
 
Group GOT U/L 
 
GPT U/L Alkaline PhosphataseU/L 
Day 0 Day 21 Day 0 
 
Day 21 Day 0 Day 21 
Control 
(D.W.)
135.8±2.1 136.0±2.5 66.4±1.88 66.8±0.3 299.8±17..55 295.2±16.9 
C.arientinum 
400 mg/kg
135.3±12.0 136.0±0.2 63±2.0 65±1.0 263±4.9 260±4.9 
C.arientinum 
200 mg/kg
135.66±2.0 135.66±2.1 63.3±2.1 63.66±5.2 263±4.8 260±4.9 
C.verum 
400mg/kg
118.0±3.4 117.3±1.4 61±1.5 60.6±9.2 219±4.0 220±3.9 
C.verum 200 
mg/kg
120.6±1.7 121±0.57 65.3±2.0 66.3±0.66 277±9.1 276.66±5.3 
C.aurantifolin 
400 mg/kg
129.3±1.4 130±0.9 61.6±2.9 61.3±1.8 254±4.1 256.3±3.2 
C.aurantifolin 
200 mg/kg
125.3±4.9 126.3±2.2 63±2.5 64.3±2.9 223±12.8 223.3±13.6 
 
(Data are expressed in mean± standard error of mean) 
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(Table 3-41) Kidney function 
 
 
 
Creatinine mg/dl Urea mg/dl Na mmol/L  K mmol/L 
 
Group
Day 0 Day 21 Day 0 Day 21 Day 0 Day 21 Day 0 Day 21 
Control(D.W.) 0.58±.08 0.56±.03 39.4±3.2 40.4±2.5 140.2±1.6 140.8±1.8 5.7±0.37 5.4±0.24 
C.arientinum 
400 mg/kg
0.80±.08 0.76±.05 41.3±1.8 40.3±3 142.6±.34 142.3±1.5 6.20±0.29 6.30±0.07 
C.arientinum 
200 mg/kg
0.93±.08 0.90±.05 45±1.7 43±4.0 146.3±.33 146.6±1.4 5.5±0.29 5.7±0.08 
C.verum 400 
mg/kg
0.63±.12 0.6±.05 59.3±2.9 58.6±2.9 147.3±.33 146.3±4 5.2±0.14 5.4±0.32 
C.verum 200 
mg/kg
0.96±.03 0.93±.08 44±1.7 43±2.3 146.3±.8 145±.5 6.0±0.2 6.2±0.26 
C.aurantifolin 
400 mg/kg
0.93±.08 0.97±.05 45±1.7 43±4 147±.33 146.6±1.4 5.5±0.29 5.7±0.08 
C.aurantifolin 
200 mg/kg
0.96±.03 0.93±.03 46.66±1.7 44.3±8.1 144.3±1.7 143±2.6 5.20±0.08 5.50±0.057
 
Data are expressed in mean± standard error of mean 
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Table (3- 42) Haematology 
 
HGB  (g/dl) RBCs (Cells/cmm3) WBCs 
(Cells/cmm3) 
Day21  Day 0  Day21  Day 0  Day2
1  
Day0 
Group
11.5±0.5  11.0±1 6.0±0.1 5.8±0.9 6.0±3 5.8±0.4 Control 
(D.W)
11.0±0.5 11.3±.8 6.3±0.3 6.0±.01 7.1±2
.  
7.3±0.1 C.arientinu
m(400mg/kg) 
10.3±0.5  10.7±.89.9±0.1 9.7±3.2 5.2±1 5.0±0.4 C.arientinu
m(200mg/kg)  
10.6±0.2 10.2±.65.9±0.2 6.0±0.3 5.8±45.6±0.2 C.verum 
(400mg/kg)
11.5±0.1 11.4±2.5.9±0.3 6.2±.15 4.8±2 4.6±0.1C.verum 
(200mg/kg) 
10.8±0.6 10.4±0.
5 
10.1±.4 10.5±.3 6.2±3 6.2  ±3 C.aurantifo
lin(400mg/kg 
10.6±0.6 10.8±.55.1±0.4 5.2±0.23.0±3
.  
2.7  ±.1C.aurantifo
lin(200mg/kg 
  
  
  
Table (3-43) Histopathology 
 
C.aurantifolin  
N=10 
C.verum  
N=10  
C.arientinum  
N=10  
Control 
N=10 
Histopat-
hological 
Findings
Day 
21  
Day 
0  
Day 
21  
Day 
0  
Day 
21  
Day 
0  
Day 
21 
Day 
0 
+  +  +  +  +  +  +  +  Normal 
hepatocytes
-  -  -  -  -  -  -  -  Fibrosis
-  -  -  -  -  -  -  -  Cirrhosis
-  -  -  -  -  -  -  -  Fatty 
infilteration
-  -  -  -  -  -  -  -  Focal 
necrosis
 
  
  
  
  
  
 
 
 
Chapter four 
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4-Discussion  
 Plants have already been utilizable sources of drugs and many of 
the currently available drugs; have been directly or indirectly extracted 
from plants. In accordance to the recommendations of the WHO Expert 
Committee, on diabetes mellitus, it is important to investigate the 
hypoglycaemic action for plants which were traditionally used in 
traditional medicine (Alarcon., et al 1998).  
Some rural old men and ladies, termed specialists, treat diabetes by some 
medicinal plants and they believe that traditional medicines are better, 
permanent cure for many diseases. So knowledge, accordingly, continue 
to provide the building blocks for the development of traditional medicine 
(Rahman and Zaman 1989). 
The limited efficacy and the draw back of the currently used 
hypoglycemic agents prompted the scientists world-wide to search for 
more effective phytomedicenes. (Rahman and Zaman 1989). 
More than 1200 species of plants have been used ethno-
pharmacologically or experimentally to treat symptoms of diabetes 
mellitus. They represent more than 725 genera in 183 families. The most 
frequently sited families are Asteraceae, Fabaceae, Poaceae, Laminaceae 
and Liliaceae. According to the taxonomy of Elghazali., et al (1999) 
C.arientinum belongs to the family Fabaceae C.verum belongs to 
Lauraceae and C.aurantifolin belongs to the family Rutaceae. 
In this study, phytochemical screening of Cicer arientinum revealed 
presence of sterol, alkaloids, saponin, cyanogenic glycosides and 
coumarins; in addition (Elghazali., et al 1999) reported presence of 
volatile oil, amino acids and starch in C.arientinum. Phytochemical 
screening of Cinnamomum verum revealed presence of triterpens, 
alkaloids, tannin and saponin, besides these (Elghazali., et al 1999) 
declared presence of volatile oil, cinnamic aldehyde as well as terpenoids. 
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Phytochemical screening of Citrus aurantifolin resulted in presence of 
sterols, alkaloids, flavonoids, saponin, cyanogenic glycosides and 
coumarins, (Elghazali ., et al 1999 ) added presence of volatile oil, 
hesperidin, vitamin B, vitamin C, and potassium and calcium citrate. On 
the basis of the above evidences it is possible that the presence of 
alkaloids, saponnins, sterols, volatile oils, glycosides, coumarins and 
flavonoides were responsible for the observed anti diabetic effect of 
C.arientinum, C.verum and C.aurantifólin. These findings  agree  with 
Grover., et al (2002) who reported that the biologically active 
components of plants with hypoglycaemic action include; flavonoides, 
alkaloids, glycosides, polysaccharides, peptidoglycans, steroids and 
terpenoides. The results of this study also agree with  the findings of  
Baskaran ., et al (1990)  who related the hypoglycaemic effect of 
Gymnema sylvestre to the presence of saponins, Ghosal., et al (1974) and 
Shani et al., (1974) who related the hypoglycaemic effect of Trigonella, 
to the presence of coumarins, De Sousa, who related the hypoglycaemic 
activity of Bauhinia  forficata to the presence of flavonoids and 
(Lotlikar., et al l996) who related the hypoglycaemic effect of 
M.charantia and M.foetida, to the presence of glycosides. 
The findings of this research disagree with the findings of  Hou., et al 
(2003) who related the hypoglycaemic activity of Lactuca indica to the 
presence of latucain C (3) and lactucaside. 
The present study was an attempt to investigate the hypoglycaemic 
and anti –diabetic effects of three medicinal plants used in folk medicine 
for the treatment of diabetes mellitus. These plants were Cicer 
arientinum, Cinnamomum verum and Citrus aurantifolin.  
As shown in tables (3-3) and (3-6) the two doses (400 and 200 mg/kg) of 
both extracts of C.arientinum, showed a significant glucose reduction 
(P<0.001) and (P<0.05) respectively after extract administration to 
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hyperglycaemic rats. The hypoglycaemic effect of both extracts, was 
greater than that produced by glibenclamide. In diabetic rats, both doses 
(400 mg/kg and 200 mg/kg) of the aqueous extract, revealed significant 
hypoglycaemic effect (P<0.05) and (P<0.001) respectively. Both doses of 
the methanolic extract, revealed a slower but highly significant (P<0.001) 
hypoglycaemic effect. Both extracts recorded glucose – lowering effect 
greater than that caused by glibencamide and insulin.  
Regarding the hypoglycaemic effect of C.verum in hyperglycaemic rats, 
the both doses of both extracts significant lowering effect (P<0.001) since 
the first hour post dose administration as shown in tables (3-9) and (3-
12).In diabetic rats, dose (400 mg/kg) of the aqueous extract reduced 
blood glucose level significantly (P<0.05) (P<0.001), 8 and 12 hours post 
dosing respectively. Neither glibenclamide nor insulin reduced blood 
glucose level of diabetic rats as shown in table (3-27) Dose (200 mg/kg) 
of the aqueous extract and both doses of the methanolic extract, exerted 
significant glucose reduction (P<0. 001) after 12 hours as demonstrated in 
table (3-30). 
In studying the hypoglycaemic effect of C.aurantifolin, doses (400 and 
200 mg/kg) of the aqueous extract reduced blood glucose of 
hyperglycaemic rats significantly (P<0.05), (P<0. 001) and (P<0. 001) at 
hours 1, 2 and 4 post dosing respectively as shown in table (3-15). 
Regarding the methanolic extract, dose (400 mg/kg) resulted in a 
significant reduction in blood glucose (P<0. 001) and (P<0.05), one and 
two hours respectively post administration of the extract. Dose (200 
mg/kg) showed a significant lowering of blood sugar (P<0.05), one hour 
after administration of extract as shown in table (3-18) 
In diabetic rats the two doses of the aqueous extract reduced blood 
glucose significantly (P<0.05), (P<0.001), 4 and 8 hours after extract 
administration respectively (table 3-33), while both doses of the 
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methanolic extract showed a significant hypoglycaemic effect (P<0.05) 
12 hours post dosing. Neither the reference drugs glibenclamide nor 
insulin reduced blood glucose, as shown in table (3-36). 
Many other hypoglycaemic plants were studied by different authors. In 
a study to determine the mechanism of the hypoglycemic activity of the 
aqueous extract of Retama Ractam (RR) in normal and streptocotocin 
induced diabetic rats, dose 10mg /kg, produced a significant decrease in 
blood. glucose level of normal rats and even more marked decrease in 
diabetic rats and a change in plasma insulin concentration after (RR) 
treatment (Mohamed, 2003).  
The aqueous extracts of Fraxinus excelsior (FE) seeds  and Silybum 
Marionum (SM) aerial part, were investigated for their hypoglycaemic 
effect in normal and Streptozotocin (STZ) diabetic rats. After 15 daily 
doses of oral administration of the aqueous extracts (2o mg/kg), a 
significant decrease of blood glucose level was produced in both normal 
and STZ diabetic rats. In addition no change in insulin level in plasma 
was observed. We conclude that aqueous extracts of FE and SM exhibit 
potent hypoglycemic and anti-hyperglycemic activities in normal and 
STZ rats, respectively, without affecting plasma insulin concentration. 
(Maghranim, et al., 2004). 
The leaf alcohol extract of the plant Annona squamosa was investigated 
for its anti-diabetic activity in diabetic rats. The findings showed the 
significant anti diabetic potential of the extract in monitoring the diabetic 
condition in diabetic rats (Annie., et al 2004).   
The effect of the extract of Origanum Vulagare leaves on blood glucose 
levels was investigated in normal and streptozotocin induced diabetic 
rats. There was a significant decrease (p < 0.05) in blood glucose, after 
single oral administration for 15 days of repeated single daily doses of the 
aqueous extract (20 mg/kg). A significant decrease on blood glucose level 
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in STZ diabetic rats was observed. The aqueous extract of Origanum 
Vulagare exhibited an anti-hyperglycemic activity in STZ rats without 
affecting plasma insulin concentration. (Lemnadri et al, 2004). 
The target plants of this present study are also subjected to 
investigation of their effects on cholesterol and triglycerides.  Both 
doses of the aqueous extract of C.arientinum showed a persistent 
significant reduction (P<0.05) on blood cholestrol of hyperglycaemic 
rats at the first and second hours post extract administration. The results 
are shown in table (3-4), while both doses of the methanolic extract 
lowered the level of blood cholestrol of hyperglycaemic rats significantly 
(P<0.001) since the first hour of extract administration. The effect 
persisted throughout the experiment as shown in table (3-7). Similar to 
glibenclamide, and insulin, neither the aqueous (table 3-22) nor the 
methanolic (3-25) extracts of C.arientinum exerted a 
hypocholesterolaemic effect in diabetic rats. 
With respect to C.verum,neither the aqueous nor the methanolic extracts 
produced significant reductions on the levels of blood cholesterol of 
hyperglycaemic as well as on diabetic  rats as indicated in tables (3-10), 
(3-13), (3-28) and (3-31). 
Both doses of the aqueous extract of C.aurantifolibn reduced blood 
cholesterol  of hyperglycaemic rats significantly (P<0.001) 1 hour post 
dosing as shown in table (3-16 ).Dose 200 mg/kg revealed a significant 
hypocholesterolaemic effect (P<0.05) as demonstratd in table (3-19).In 
diabetic rats,similar to glibenclamide and insulin,neither the aqueous nor 
the methanolic extracts reduced blood cholesterol as shown in tables(3-
34) and (3-37) respectively.  
Concerning the effect of these plants on the level of blood triglycerides 
of hyperglycaemic rats, the two doses of the aqueous extract  of 
C.arientinum, expressed a significant reduction (P<0.05) two hours post 
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dosing as compared to the control The results are  shown in table (3-5). 
Both doses of the methanolic extract lowered the level of triglycerides 
significantly (P<0.001) since the first hour of extract administration. The 
effect persisted throughout the experiment as shown in table (3-8).  
In diabetic rats, dose (400 mg/kg) of the aqueous as well as the 
methanolic  extracts of C.arientinum reduced the level of blood 
triglycerides significantly (P<0.001), twelve hours after 
extract.administration while dose 200mg/kg showed a more persistent 
significant lowering effect (P<0.05), (P<0.05) and (P<0.001) respectively 
4, 8 and 12 hours post dosing. The results are shown in table (3-23).  
Similar to glibenclamide, dose 200 mg/kg showed no lowering effect on 
blood triglycerides, while Insulin reduced blood triglycerides 
significantly (P<0.001) 4, 8, and 12 hours post administration. Table (3-
26). 
In studying the effect of C.verum on the level of blood triglycerides of 
hyperglycaemic rats,  the results revealed  that none of the two doses of 
the aqueous extract, produced a significant lowering effect on  the level 
of blood triglycerides as indicated in table (3-11), while the two doses of 
the methanolic extract produced a significant reduction (P<0.05)  2 and 4 
hours post dosing, as compared to the control (table 3-14).In diabetic 
rats, both doses of the aqueous extract of C.verum produced a significant 
lowering effect (P<0. 001). on the level of blood triglycerides of diabetic 
rats  8 and 12 hours post dosing. The results are illustrated on (table 3-
29). The methanolic extract, as well as the reference drug (insulin) 
showed a significant lowering effect (P<0. 001) on the level of blood 
triglycerides, twelve hours post dosing, as shown  in table (3-32 ). 
In studying the effect of C.aurantifolin on the level of blood triglycerides 
of hyperglycaemic rats, dose (400 mg/kg) of the aqueous extract, 
revealed a significant reduction (P<0. 001) 2 and 4 hours post dose 
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administration as shown in table (3-17), while the methanolic extract 
showed no significant reduction as illustrated in table (3-20). In diabetic 
rats, both doses of the aqueous extract of C.aurantifolin as well as the 
reference drug (insulin) reduced the level of blood triglycerides 
significantly (P<0. 001) since the 4th hour, while glibenclamide showed 
no effect. The results are shown in table (3-35). The two doses of the 
methanolic extract of C.aurantifolin reduced the level of blood 
triglycerides of diabetic rats significantly (P<0.05), (P<0. 001) 8 and 12 
hours post extract administration. The reference drug insulin produced a 
highly significant reduction (P<0. 001).since the 4th hour and the effect 
persisted till the 12th hour. Glibenclamide showed no effect. The results 
are shown in table (3-38). 
Other studies on the hypolipidaemic effects of hypoglycaemic plants  are 
conducted worldwide. Oral administration of Trigonella foenum-graecum 
seeds for 5 successive days to normal rabbits resulted in a significant 
reduction of serum glucose concentration and showed no effect on 
cholesterol and triglycerides. In diabetic rabbits, administration of the 
same extract of the seeds of Trigonella foenum-graecum, significantly 
reduced serum glucose and cholesterol (Al-Hussary 1993).  
A study performed by Shiva 1998 revealed that Trigonella foenum 
gracecum lowers blood cholesterol and triglycerides. A study conducted 
by Agrawal., et al 1996, verified that Ocimum sanctum, reduced blood 
glucose, uric acid, total amino acids, cholesterol triglycerides and 
phospholipids. 
  The suggested mode of action for the study plants is inhibiting 
gluconeogenesis and facilitating glucose absorption by the cells i.e. 
increase glucose metabolism and trigger release of insulin. Leung and 
Foster, (1996) reported that C.verum has shown a strong lipolytic action 
(hydrolyze fats). Bruneton, 1995 reported that the essential oils in 
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C.verum have demonstrated antifungal, antiviral, bactericidal and 
larvicidal actions.  
Many previous studies were performed to investigate the mode of action 
of some hypoglycaemic plants. The mechanism may differ from one plant 
to another but the net effect is more or less the same. Ptercarpus 
marsupium has been proved for their regenerative/repair activity of B-
islets of pancreas. It has insulin like property in cases of newly diagnosed 
Non-Insulin Dependent Diabetes Mellitus (Gupta 1983) and (Shah 1967).  
The herbal therapy Gymnema Sylvestra (gumar) appears to bring about 
glucose homeostasis through increased serum insulin levels provided by 
repair/regeneration of endocrine pancreas. G. Sylvestra treatment helped 
to maintain the weight of pancreas; number of beta- cells in diabetic 
subjects.Gymremic acid had lowering effects in blood glucose level 
(Murakami., et al 1996).  
Aegel marmaelos exerts a hypoglycaemic effect, by improving digestion 
and reducing sugar and urea Embilica aplicenel (Indian gooseberry) 
produces a hypoglycaemic effect by stimulating pancreatic secretion of 
insulin (Upadhyay., et al 1996). Kohli and Singh (1993) found that 
Eugenia jambiana prevents pathological conversion of starch to glucose, 
thus reducing glucose level in blood. The flavonoids quercetin and  
myricetin  have also  been reported  to be hypoglycemic(Rahman and 
Zaman 1989),but they are  known to  be potent inhibitors of protein 
tyrosine  kinase the activity of which  is essential  in the post  receptor –
binding activity of insulin. Most hypoglycemic plant constituents, such as 
alkaloid, salicylic acid are also growth inhibitors and hypoglycemic 
agents (Geahlen ., et al 1989),The mode of action produced by the fruits, 
leaves and roots of Momordica charantia in reducing blood glucose, is 
supposed to be through increasing glucose uptake in the liver cells and by 
acting as plant insulin (Kavikumar et al 1997).  
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  In studying the toxicity of the study plants, neither C. 
arientinum nor C.veum or C.aurantifolin showed any change in the levels 
of  T.WBCs , T.RBCs and Hb as shown in table (3-39).Concerning liver 
function tests, neither C.arientinum nor C.veum or C.aurantifolin showed 
any change in the levels of  GOT, GPT  and ALP as shown in table (3-
40). Concerning kidney function tests, neither C.arientinum nor C.veum 
or C.aurantifolin showed any change in the levels of Urea, Creatinine, Na 
and K as shown in table (3-41). None of the study plants showed any 
histopathological findings as shown in table (3 - 42).  
Unlike our findings, organ lesions accompanied by leucopenia, anaemia 
and alterations in serum GOT, GPT and ALP activities and 
concentrations of total protein, albumin, urea, bilirubin and other serum 
constituents was reported in rats fed Nerium oleander leaves (Al – Yahya 
et al., 2000). Increased ALP activity was reported in chicken fed 
Azadirachta indica due to excretory dysfunction of the liver (Ibrahim, 
1990). Graded doses of Nature Cure Bitters (Hilleria latifolia, Citrus 
aurantifolia and Xylopia aethiopica) were administered daily (100, 200 
and 400 mg/kg) to rats for 28 days, a significant decrease in ALP and in 
total protein occurred in all groups with an elevated level of albumin and 
GPT (Stanley et al, 2000). Guiera sengalensis and Ambrosia maritime, 
which were used in folk medicine for treatment of diabetes mellitus, 
caused hyperplasia to the pancreas (Ahmed, 1987). 
 
 
 
 
 
Conclusion  
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In this study, it was noticed that the three study plants 
C.arientunum, C.verum and C.aurantifolin, revealed significant 
hypoglycaemic effect in both type I and type II Diabetes mellitus. 
Cinnanomum verum was the most effective one. The onset of action for 
the three plants was earlier in type II diabetes mellitus. In type 11, all 
plants were more effective than the reference drug Glibenclamide, 
similarly in type I all plants showed a hypoglycaemic effect greater than 
that caused by the reference drug Insulin. 
Regarding the effect of these plants in blood lipids, none of them 
affected the level of blood cholesterol in type I diabetic rats. Cicer 
arientinum was the most effective one followed by Citrus aurantifolin. 
With respect to triglycerides, the methanolic extract of C.arientinum was 
the most effective one of the three study plants in reducing blood 
triglycerides in type II, while the aqueous extract of C.aurantifolin was 
highly effective in reducing blood triglycerides of diabetic rats. The effect 
of Cinnanomum verum was the least and was more pronounced in type I. 
 Regarding toxicity all three plants proved great safety in their 
continuous use according to their effects on liver functions, kidney 
functions and blood haemogram.Furthermore a dose of 10 g / kg was 
reached without any death in the experimental rats, which ensures great 
safety of the tested plants. 
 From the results of this study, it can be concluded that C. 
arientinum, C.verum and C.aurantifolin are highly effective and safe 
hypoglycaemic agents for both types of diabetes mellitus. Furthermore 
they act as moderate hypolipidaemic agents. 
 
 
 
Recommendations 
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Sudan in a very rich country in medicinal herbal plants whose 
scientific knowledge is almost unknown, thus the following guidelines 
are recommended:  
 Development of cultivation of indigenous medicinal plants. 
 Development of well equipped laboratories for the proper 
assessment of different herbs including C.arientinum, C.verum and 
C.aurantifolin. 
 Health education on beneficial effects of natural plants. 
 Establishing more research centers for studying and training staff 
and students in herbal plants. 
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